document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align center confidential treatment requested insite style margin margin bottom font size font family time roman align center vision incorporated confidential portion style margin margin bottom font size font family time roman align center this document have been redacted have style margin margin bottom font size font family time roman align center been separately filed with commission style margin margin bottom font size font family time roman exclusive licence style margin margin bottom font size font family time roman development agreement style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign dated valign bottom valign bottom align center nbsp january nbsp valign bottom valign bottom style font size height height colspan height colspan style font family time roman font size valign insite nbsp vision nbsp incorporated nbsp valign bottom valign bottom valign bottom valign bottom style font family time roman font size valign nicox valign bottom valign bottom valign bottom valign bottom table style margin margin bottom font size font family time roman execution version style page break before always size style color width align center style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom definition interpretation valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom appointment license relationship party valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom payment valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom information valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom collaboration development committee valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom manufacturing committee valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom development regulatory valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom manufacture supply product valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom commercialisation obligation nicox valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom product recall withdrawal quarantine valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom confidential information valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom representation warranty insite valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom representation warranty nicox valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom representation both party valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom indemnification insurance damage valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom intellectual property valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom trademark valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom compete valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom term termination agreement valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom effect termination valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom bankruptcy valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom publicity valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom miscellaneous valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix product initial indication valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix country territory valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix insite mark valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix existing insite patent valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix pfizer patent valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman part agreement valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman part activity valign bottom valign bottom valign bottom valign bottom style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix outline development activity valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman part nicox press release valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman part insite press release valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix custom manufacturing equipment valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix development activity valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix disclosure schedule valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman appendix pfizer agreement valign bottom nowrap valign bottom nbsp nowrap valign bottom align right nowrap valign bottom nbsp nbsp table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign nbsp date valign bottom valign bottom nbsp valign bottom align right nbsp january nbsp nowrap valign bottom nbsp nbsp table style margin margin bottom margin left font size font family time roman party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite vision incorporated delaware corporation having place business atlantic avenue alameda insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox french corporation having place business drakkar acirc timent route dolines sophia antipolis valbonne france nicox table style margin margin bottom margin left font size font family time roman each party together party style margin margin bottom margin left font size font family time roman recital style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite company developing ophthalmology therapeutic owner licensee insite technology defined below certain product based thereon table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox wish obtain exclusive right develop commercialise product defined below pursuant term this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox agreed take insite agreed grant exclusive licence territory defined below develop commercialise product independent contractor basis global licence manufacture perform certain development product commercialization territory term this agreement table style margin margin bottom margin left font size font family time roman operative provision style margin margin bottom margin left font size font family time roman therefore consideration mutual promise condition herein party hereto agree contract follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign definition interpretation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement following expression have meaning against them below except where context otherwise requires table style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman additional indication valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman adverse event valign bottom valign bottom mean unintended unfavourable sign symptom effect disease temporally associated with pharmaceutical product other event defined within guideline guideline other applicable regulatory authority style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman affiliate valign bottom valign bottom mean person ultimate holding company company which controlled such holding company purpose this definition controlled mean direct indirect ownership fifty cent more issued share other interest profit person ability otherwise control direct decision board director equivalent governing body thereof style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom mean active pharmaceutical ingredient product style font size height height colspan style font family time roman font size valign approved manufacturer valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman approved study valign bottom valign bottom mean clinical study concerning product agreed collaboration development committee either part agreed development plan pursuant clause style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman approved trade mark valign bottom valign bottom mean country country applicable region region table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign bottom nbsp valign bottom valign bottom basis trade mark brand name nicox other than insite mark that been approved with product applicable regulatory authority such country applicable such region territory style font size height height colspan style font family time roman font size valign authorized resellers valign bottom valign bottom mean third party selected nicox distribute assist nicox distribution product style font size height height colspan style font family time roman font size valign background information valign bottom valign bottom mean development information commercial safety information including clinical clinical data information chemistry manufacturing control data manufacturing data relating product equivalent product durasite technology relating field that controlled insite effective date including that clause style font size height height colspan style font family time roman font size valign business valign bottom valign bottom mean other than saturday sunday when bank open business paris france oakland california style font size height height colspan style font family time roman font size valign collaboration development committee valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign competitor nicox valign bottom valign bottom mean entity that sell pharmaceutical product territory that directly competitive with product territory virtue such entity product being sold field style font size height height colspan style font family time roman font size valign confidential information valign bottom valign bottom mean secret confidential proprietary information data whether provided written oral provided information data provided orally subsequently provided other form referred this definition graphic video computer other material form provided party other party pursuant this agreement including information generated behalf party pursuant this agreement disclosed other party which include information relating disclosing party existing proposed research development effort sale supply forecast financial projection other sale marketing information unpublished patent application business product other material that have been made available disclosing party general public term this agreement shall also deemed confidential information each party style font size height height colspan style font family time roman font size valign control control controlled valign bottom valign bottom mean with respect specific material product know patent confidential information other intellectual property right that applicable party owns licence from third party under such material product know patent confidential information other intellectual property right ability grant other party licence licence thereto contemplated under this agreement without violating term agreement other arrangement with right third party existing date which such licence licence granted provided that specific material product know patent confidential information other intellectual property right that acquired licensed party after effective date that would otherwise considered under control such party shall deemed under control such party application such definition context licence licence granted other party contemplated under this agreement would require granting party make additional payment royalty third party connection with such licence licence grant unless other party agrees additional payment royalty third party accordance with clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign valign bottom valign bottom basis trade mark brand name nicox other than insite mark that been approved with product applicable regulatory authority such country applicable such region territory style font size height height colspan style font family time roman font size valign current manufacturer valign bottom valign bottom mean such other manufacturer insite engages from time time manufacture product equivalent product distribution outside territory style font size height height colspan style font family time roman font size valign custom manufacturing equipment valign bottom valign bottom mean manufacturing equipment currently owned insite listed appendix together with upgrade replacement improvement thereto from time time style font size height height colspan style font family time roman font size valign develop developed development valign bottom valign bottom mean activity that relate obtaining maintaining expanding regulatory approval product field territory developing ability manufacture undertaking manufacture clinical commercial quantity product field territory development includes manufacturing related technology development validation transfer conducting clinical trial territory preparation submission review development data information purpose submission regulatory authority territory obtain maintain expand regulatory approval product territory manufacturing process development transfer scale qualification validation including study commercial supply product related regulatory affair including regulatory support necessary product maintenance developing other cognate expression shall defined accordingly style font size height height colspan style font family time roman font size valign development plan valign bottom valign bottom mean development plan agreed collaboration development committee relation product field pursuant clause style font size height height colspan style font family time roman font size valign distribute distributing distribution valign bottom valign bottom mean following distribute purchase store warehouse market promote sell offer sale provide sample import export otherwise contract with manage authorized resellers ship including grant licence required such purpose style font size height height colspan style font family time roman font size valign durasite technology valign bottom valign bottom mean proprietary ophthalmic drug delivery formulation technology controlled insite that contains cross linked polyacrylic acid polymer that currently known durasite consists polycarbophil sodium chloride edta least single active pharmaceutical ingredient such technology adapted insite accordance with this agreement required product obtain regulatory approval field territory provided that durasite technology shall include next generation cross linked polyacrylic acid polymer technology such durasite insite patented improvement after payment period insite patented improvement created after fifth anniversary effective date unless licence agreed party pursuant provision clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign valign bottom valign bottom technology related information data improvement resulting from independent study conducted insite under clause except extent nicox acquires right such information data improvement under clause applicable clause style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman durasite valign bottom valign bottom mean proprietary drug delivery formulation technology that contains cross linked polyacrylic acid polymer chitosan another cationic polymer which formulation currently known durasite style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman effective date valign bottom valign bottom mean date this agreement style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom mean european medicine agency successor entity thereto style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman equivalent product valign bottom valign bottom mean version product extent identical them adapted developed used intended outside territory behalf insite under licence from insite extent term such licence enable insite disclose licensee version product element thereof nicox without further payment provided that insite shall reasonable commercial effort obtain such enabling term licence agreement with such licensee style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman existing insite patent valign bottom valign bottom mean patent appendix patent territory outside territory with respect patent covering manufacture development other than clinical development product that claim priority from them provided that avoidance doubt existing insite patent shall include pfizer patent style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman exploit exploiting exploitation valign bottom valign bottom mean development distribution manufacture style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom mean united state food drug administration successor entity thereto style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman field valign bottom valign bottom mean topical treatment human ophthalmic disease infection inflammatory other condition human provided that avoidance doubt field shall include veterinary application style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman first commercial sale valign bottom valign bottom mean with regard specific product country territory first commercial sale nicox specified reseller such product third party consumption such country after nicox such specified reseller receipt regulatory approval such product such country such product promotional sampling compassionate purpose that customary prevailing pharmaceutical industry shall considered commercial sale hereunder style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom mean effort more employee insite performing work related this agreement equivalent effort full time insite employee year consisting total work hour year table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font size height height colspan style font family time roman font size valign good clinical practice valign bottom valign bottom mean then current regulatory standard designing conducting performing monitoring auditing recording analysing reporting clinical trial regulation guidance document promulgated thereunder amended from time time required regulatory authority applicable territory style font size height height colspan style font family time roman font size valign good laboratory practice valign bottom valign bottom mean then current regulatory standard laboratory activity chemical chemical product pharmaceutical biologicals regulation guidance document promulgated thereunder amended from time time required regulatory authority applicable territory style font size height height colspan style font family time roman font size valign good manufacturing practice valign bottom valign bottom mean applicable standard principle guideline pertaining then current good manufacturing practice applicable territory they relate product equivalent product including standard equipment facility production quality control established regulatory authority applicable territory style font size height height colspan style font family time roman font size valign governmental authority valign bottom valign bottom mean court agency department authority other instrumentality foreign federal state county city other political subdivision style font size height height colspan style font family time roman font size valign group valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign improvement valign bottom valign bottom mean improvement enhancement development modification alteration background information insite technology product including step process manufacture that would enhance efficacy safety ease reduce cost time manufacture render other preferable improve shall have corresponding definition style font size height height colspan style font family time roman font size valign initial indication valign bottom valign bottom mean indication detailed appendix amended accordance with clause style font size height height colspan style font family time roman font size valign insite authorized representative valign bottom valign bottom mean chief executive officer insite delegated senior representative style font size height height colspan style font family time roman font size valign insite change control valign bottom valign bottom mean sale substantially insite consolidated asset single transaction series related transaction competitor nicox acquisition competitor nicox insite common stock possessing majority ordinary voting power elect director insite merger consolidation insite with into competitor nicox regardless which entity surviving entity after giving effect such merger consolidation holder insite voting security immediately prior such merger consolidation voting security surviving resulting entity representing than majority ordinary voting power elect director surviving resulting entity style font size height height colspan style font family time roman font size valign insite data valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign insite data licensee valign bottom valign bottom third party whom insite licensed insite technology background information whose information including clinical clinical data information chemistry manufacturing control data manufacturing data relating product equivalent product durasite technology relating field assigned licensed back insite term which permit disclosure nicox without further payment table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font size height height colspan style font family time roman font size valign insite improvement valign bottom valign bottom mean improvement where insite sole owning party intellectual property right improvement insite right intellectual property right jointly owned improvement improvement owned third party that controlled insite capable license nicox pursuant clause style font size height height colspan style font family time roman font size valign insite mark valign bottom valign bottom mean trademark trade name logo design insite with product field territory appendix style font size height height colspan style font family time roman font size valign insite patented improvement valign bottom valign bottom mean insite improvement that covered patent territory style font size height height colspan style font family time roman font size valign insite patented improvement valign bottom valign bottom mean insite improvement that covered patent territory style font size height height colspan style font family time roman font size valign insite patent valign bottom valign bottom mean existing insite patent other patent controlled insite during term extent such patent cover manufacture sale product field durasite technology with respect product field provided that insite patent will limited patent territory except with respect patent covering manufacture development other than clinical development product provided further that insite patent shall include pfizer patent provided further that insite patent excludes insite patent covering insite patented improvement after payment period patent covering information data improvement resulting from independent study conducted insite under clause except extent nicox acquires right such information data improvement under clause applicable clause patent controlled insite result licence agreement with third party that insite data licensee except extent they included under clause style font size height height colspan style font family time roman font size valign insite technology valign bottom valign bottom mean insite mark insite patent pfizer patent durasite technology know miscellaneous style font size height height colspan style font family time roman font size valign intellectual property right valign bottom valign bottom mean patent trademark copyright right design database right know trade secret right confidential information other intellectual property right form protection similar equivalent nature effect which subsist anywhere world whether registered capable registration together with application registration right apply above style font size height height colspan style font family time roman font size valign valign bottom valign bottom style font size height height colspan style font family time roman font size valign european territory valign bottom valign bottom mean france germany italy spain united kingdom style font size height height colspan style font family time roman font size valign know valign bottom valign bottom mean technical information know controlled insite effective date during term relating product equivalent product durasite technology with respect thereto each case relating field including manufacture distribution product field including table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign valign bottom valign bottom trade secret report product specification formulation data analysis manufacturing process result test related data information together with common statutory right protecting such know including action breach confidence similar analogous right whether arising granted under france other jurisdiction provided that know excludes information know related insite patented improvement created after fifth anniversary effective date unless licence agreed party pursuant provision clause information data improvement resulting from independent study conducted insite under clause except extent nicox acquires right such information data improvement under clause applicable clause provided further that know excludes patent trademark style font size height height colspan style font family time roman font size valign manufacture valign bottom valign bottom mean activity related production manufacture processing control including process control batch control filling finishing testing packaging labelling inspection release receiving holding storing shipping product starting material packaging material with respect thereto intermediate stage device part foregoing including process cost optimization process qualification validation commercial manufacture stability release testing quality assurance quality control manufactured manufacturing other cognate expression shall defined accordingly style font size height height colspan style font family time roman font size valign manufacturing committee valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign agreement valign bottom valign bottom mean agreement referred part appendix style font size height height colspan style font family time roman font size valign agreement country valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign miscellaneous valign bottom valign bottom mean intellectual property right controlled insite effective date during term other than durasite technology insite patent pfizer patent insite mark know that necessary distribute manufacture product field that otherwise reasonably directly related product including their bottle packaging material similar item provided that miscellaneous excludes intellectual property right next generation cross linked polyacrylic acid polymer technology such durasite patent trademark insite improvement information data improvement resulting from independent study conducted insite under clause style font size height height colspan style font family time roman font size valign sale valign bottom valign bottom mean gross amount invoiced nicox specified reseller from product sold otherwise provided consideration nicox such specified reseller nicox customer reduced following amount allowed included reported sale calculated accordance with international financial reporting standard ifrs consistently applied customary prevailing pharmaceutical industry previously deducted from amount invoiced table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp amount actually allowed trade selling commission volume quantity discount including early cash discount style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp amount repaid credited reason defect recall accrued actual return rebate allowance good because retroactive price reduction specifically identifiable relevant product style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp rebate administrative paid medical health care organization line with approved contract term style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp rebate resulting from direct indirect government agency thereof rebate programme chargeback programme style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp rebate paid wholesaler inventory management programme distribution management agreement accordance with nicox practice consistently applied style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp amount specifically identified included invoiced amount sale excise duty including custom duty other governmental charge including payment made united kingdom government department under pharmaceutical pricing regulatory scheme pprs similar programme country territory imposed directly actually paid nicox specifically excluding income style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp transportation cost amount specifically identified included invoiced amount including insurance shipping freight handling charge style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom font size font family time roman product sold otherwise commercially disposed transaction that length between buyer seller then gross amount included calculation sale shall amount that would have been invoiced transaction been conducted length such amount that would have been invoiced shall determined wherever possible reference average selling price relevant product length transaction relevant country foregoing shall apply style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp nbsp sale other disposition product consideration cost reasonable cost plus basis nicox specified resellers clinical trial style font size margin margin bottom nbsp style margin margin bottom margin left text indent font size font family time roman nbsp nbsp nbsp nbsp nbsp nbsp disposition product consideration cost reasonable cost plus basis nicox specified resellers sample promotion otherwise donation example profit institution government agency commercial purpose compassionate style font size height height colspan style font family time roman font size valign nicox agent valign bottom valign bottom mean those employee font style white space nowrap contractor font consultant nicox assist nicox directly indirectly running nicox business performing service related nicox business relation product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font size height height colspan style font family time roman font size valign nicox authorized representative valign bottom valign bottom mean chief executive officer nicox delegated senior representative style font size height height colspan style font family time roman font size valign nicox change control valign bottom valign bottom mean sale substantially nicox consolidated asset single transaction series related transaction acquisition nicox common stock possessing majority ordinary voting power elect director nicox merger consolidation nicox with into regardless which entity surviving entity after giving effect such merger consolidation holder nicox voting security immediately prior such merger consolidation voting security surviving resulting entity representing than majority ordinary voting power elect director surviving resulting entity style font size height height colspan style font family time roman font size valign nicox customer valign bottom valign bottom mean party party excluding avoidance doubt specified resellers purchase product from nicox specified reseller style font size height height colspan style font family time roman font size valign nicox improvement valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign nicox licensed data valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign patent valign bottom valign bottom mean patent patent application including addition division continuation continuation part reissue examination extension renewal thereof whatever legal form whatever legal title they granted including right arising respect thereof pursuant supplementary protection certificate including registered design style font size height height colspan style font family time roman font size valign payment period valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign pfizer valign bottom valign bottom mean pfizer style font size height height colspan style font family time roman font size valign pfizer agreement valign bottom valign bottom mean exclusive license agreement entered into insite pfizer february relating pfizer patent attached appendix together with amendment thereto agreed between pfizer insite which extent they adversely affect nicox have been approved nicox writing style font size height height colspan style font family time roman font size valign pfizer patent licensee valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign pfizer patent valign bottom valign bottom mean patent controlled insite effective date forth appendix other patent controlled insite during term each case through licence under pfizer agreement extent such patent cover manufacture sale specified product field durasite technology with respect specified product field provided that pfizer patent will limited patent territory except with respect patent covering manufacture development other than clinical development specified product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font size height height colspan style font family time roman font size valign pricing reimbursement approval valign bottom valign bottom mean with respect country group country territory pricing reimbursement approval product appropriate governmental authority said country group country that required either legally market sell product field said country group country market sell product field said country group country reasonable commercial basis style font size height height colspan style font family time roman font size valign product valign bottom valign bottom mean product known effective date azasite azasite xtra bromsite listed appendix such product adapted accordance with this agreement required their regulatory approval field territory improved style font size height height colspan style font family time roman font size valign quarter valign bottom valign bottom mean each three month period commencing january nbsp april july october year style font size height height colspan style font family time roman font size valign regulatory approval valign bottom valign bottom mean authorization licence approval granted regulatory authority which necessary desirable develop distribute manufacture otherwise exploit pharmaceutical product including those which necessary desirable exploit product field style font size height height colspan style font family time roman font size valign regulatory authority valign bottom valign bottom mean relation country region area governmental department authority other regulatory agency authority regulating authorizing development manufacture distribution other commercialization pharmaceutical product including outside territory europe individual competent authority member state individual competent authority elsewhere territory style font size height height colspan style font family time roman font size valign regulatory dossier valign bottom valign bottom mean those document submitted support application regulatory approval together with subsequent correspondence reporting required maintain regulatory approval product style font size height height colspan style font family time roman font size valign regulatory requirement valign bottom valign bottom mean applicable regulatory requirement under regulatory authority style font size height height colspan style font family time roman font size valign regulatory submission valign bottom valign bottom mean application regulatory dossier like submitted regulatory authority purpose conducting clinical trial notifying obtaining regulatory approval from that regulatory authority maintain regulatory approval including filing pharmacovigilance report style font size height height colspan style font family time roman font size valign royalty valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign second contract manufacturer valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign specified product valign bottom valign bottom mean product known effective date azasite azasite xtra such product adapted modified following effective date accordance with this agreement improved style font size height height colspan style font family time roman font size valign specified resellers valign bottom valign bottom mean company nicox group permitted under clause except that purpose determining whether company nicox group threshold control under clause will require ownership only more issued share authorized resellers appointed directly nicox respect sale them european territory person table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font size height height colspan style font family time roman font size valign valign bottom valign bottom licensed nicox under pfizer patent distribute have distributed specified product field territory other authorized reseller licensee whose agreement with nicox distribution product field territory provides such authorized reseller licensee nicox royalty sale product rather than transfer price purchase product from nicox style font size height height colspan style font family time roman font size valign term valign bottom valign bottom mean period this agreement described clause style font size height height colspan style font family time roman font size valign territory valign bottom valign bottom mean country listed appendix style font size height height colspan style font family time roman font size valign third party patent valign bottom valign bottom meaning given clause style font size height height colspan style font family time roman font size valign valign bottom valign bottom style font family time roman font size valign year valign bottom valign bottom mean each month period commencing january ending december relevant portion thereof during term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reference this agreement provision statute shall construed reference those provision amended enacted extended relevant time shall also include subordinate enabling legislation relating relevant statute table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign heading this agreement inserted convenience reference only intended part affect meaning interpretation this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reference person shall include individual firm corporation trust unincorporated association partnership other entity governmental authority each case whether having separate legal personality table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reference word include including similar term construed implying limitation general word introduced word other similar term shall given restrictive meaning reason fact that they preceded followed word indicating particular class matter thing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign except where context specifically requires otherwise word importing gender shall treated importing gender word importing individual shall treated importing corporation vice versa word importing singular shall treated importing plural vice versa word importing whole shall treated including reference part table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign event inconsistency between main body this agreement appendix main body shall prevail table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign appendix this agreement incorporated into this agreement reference this agreement appendix party appendix clause reference respectively party appendix clause this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign right obligation this agreement referencing relating pfizer patent pfizer agreement apply solely relation specified product other product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign appointment licence relationship party table style margin margin bottom margin left font size font family time roman appointment style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite hereby appoints nicox exclusive distributor purpose distributing product field territory during term nicox appoint authorized resellers distributor purpose such distribution product which authorized resellers themselves appoint further distributor through multiple tier which further distributor will also deemed authorized resellers hereunder table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite hereby grant nicox exclusive subject clause licensable provided pursuant clause licence under background information insite technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign distribute have distributed product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clinically develop have developed product field territory including avoidance doubt register have registered product field territory nbsp develop have developed other than clinical development product anywhere world field purpose distribution field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign manufacture have manufactured product anywhere world above purpose table style margin margin bottom margin left font size font family time roman during term thereafter extent expressly provided clause provided that with respect pfizer patent foregoing licence solely extent greater than right licence granted insite under pfizer agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox accepts such appointment licence term condition forth herein nicox agrees behalf itself nicox agent authorized resellers other licensee follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox shall develop product outside field nicox shall promote solicit order sell otherwise distribute product outside territory outside field table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign licence right granted nicox under this agreement shall include right conduct clinical trial outside territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox engage third party distribute product authorized resellers country country territory provided that nbsp such engagement must pursuant written agreement must contain provision that consistent with applicable term condition this agreement including term condition background information insite technology including obligation nondisclosure insite confidential information least restrictive those forth clause nbsp nicox shall remain responsible compliance with such applicable term condition this agreement such authorized resellers without prejudice foregoing clarification nicox liability insite respect breach authorized reseller such applicable term condition this agreement shall limited amount damage recovered nicox from authorised reseller respect breach that represents loss suffered insite direct result breach provided that nbsp nicox shall terminate applicable authorized reseller agreement authorized reseller fails timely cure material breach within remedy period permitted applicable authorized reseller agreement provided such remedy period consistent with remedy period forth clause which authorized reseller agreement must provide that nicox right terminate authorized reseller agreement under term consistent with more favourable termination right insite under this agreement nbsp nicox shall take commercially reasonable step enforce provision authorized reseller agreement that mirror term condition this agreement where authorized reseller result engagement nicox hereunder licensee right background information insite technology provision clause shall apply table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox shall distribute shall require authorized resellers other licensee distribute product territory circumstance which nicox such authorized reseller other licensee know reasonably should know such product will distributed sold outside territory subject applicable being acknowledged that unlawful prevent restrict parallel import between certain country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign licence right granted nicox under this agreement shall include right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign develop distribute manufacture otherwise exploit nicox expressly covenant that shall shall grant affiliate authorized reseller other licensee other third party right develop distribute manufacture otherwise exploit background information insite technology connection with product other than product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign distribute otherwise exploit nicox expressly covenant that shall shall grant affiliate authorized reseller other licensee right distribute otherwise exploit product background information insite technology connection with product outside field outside territory provided that this clause will limit development manufacturing product within field provided clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except provided clause insite shall retain right under background information insite technology nbsp develop have developed make have made have used product field territory solely purpose sale other distribution outside field outside territory excluding right carry clinical development respect human subject territory without prior written consent nicox such consent unreasonably withheld nbsp carry perform task responsibility under this agreement including pursuant clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign extent required conformance with applicable nicox shall mark product with number applicable insite patent pfizer patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign avoidance doubt licence granted under clause includes right insite technology related bottle other packaging material similar item respect product nicox exploitation product field territory including right make improvement such insite technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox grant licence licence under this agreement provided that nbsp licence granted under this agreement must pursuant written agreement must contain provision that consistent with applicable term condition this agreement including term condition background information insite technology including obligation nondisclosure insite confidential information least restrictive those forth clause nbsp nicox shall remain responsible compliance with such applicable term condition this agreement licensee nbsp nicox will provide insite with copy written agreement with licensee within thirty nbsp licence cover pfizer patent within eight nbsp execution thereof nbsp licence right under pfizer patent will also require pfizer prior approval compliance with term pfizer agreement including section nbsp such licensee pfizer patent licensee without prejudice foregoing clarification nicox liability insite respect breach licensee such applicable term condition this agreement shall limited amount damage table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign recovered nicox from licensee respect breach that represents loss suffered insite direct result breach provided that nbsp nicox shall terminate applicable licence agreement licensee fails timely cure material breach within remedy period permitted applicable licence agreement provided such remedy period consistent with remedy period forth clause which licence agreement must provide that nicox right terminate licence agreement under term consistent with more favourable termination right insite under this agreement nbsp nicox must take commercially reasonable step enforce provision licence agreement that mirror term condition this agreement table style margin margin bottom margin left font size font family time roman relationship party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox nicox agent authorized resellers other licensee where applicable shall acting independent contractor time while this agreement effect shall acting performing obligation employee agent joint venturer franchisor franchisee insite purpose nicox nicox agent authorized resellers other licensee where applicable shall have right power authority create obligation express implied behalf insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign consideration right granted nicox hereunder nicox shall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign make payment three million dollar million insite effective date provided received valid invoice such amount such later date which within five business after receiving such invoice table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite each product nbsp milestone payment occurrence first pricing reimbursement approval product european territory nbsp milestone payment forth table below occurrence first occur obtaining nicox authorised resellers specified resellers other licensee nicox marketing approval product forth below relevant indication forth below either nbsp centralised procedure nbsp least three nbsp country european territory either case later than relevant longstop date stated accordance with following table table style font size margin margin bottom nbsp align right table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman product valign bottom nbsp nbsp valign bottom style border bottom solid style margin margin bottom font size font family time roman indication valign bottom nbsp nbsp valign bottom style border bottom solid milestone valign bottom nbsp valign bottom style border bottom solid longstop date style font size height height colspan height colspan height colspan bgcolor cceeff style font family time roman font size valign azasite valign bottom nbsp nbsp valign bottom style margin margin bottom font size font family time roman bacterial conjunctivitis style margin margin bottom margin left font size font family time roman additional clinical trial style margin margin bottom margin left font size font family time roman with additional clinical trial valign bottom nbsp nbsp valign bottom style margin bottom margin font size font family time roman valign bottom nbsp valign bottom nbsp march nbsp style margin bottom margin font size font family time roman march style font size height height colspan height colspan height colspan style font family time roman font size valign azasite xtra valign bottom nbsp nbsp valign indication valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom march style font size height height colspan height colspan height colspan bgcolor cceeff style font family time roman font size valign bromsite valign bottom nbsp nbsp valign bottom style margin left font size font family time roman pain inflammation post cataract surgery valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom march style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom nbsp nbsp valign bottom style margin left font size font family time roman each subsequent indication which separate marketing authorization required valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom none table style margin margin bottom margin left font size font family time roman each milestone shall paid only once each product save expressly above style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite following sale milestone upon first reaching following sale threshold aggregating sale product territory consecutive month period table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman sale during consecutive month period valign bottom nbsp nbsp valign bottom style border bottom solid milestone payment amount bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom table style margin margin bottom margin left font size font family time roman each milestone shall paid only once style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign upon nicox becoming aware occurrence each event triggering payment under clause nicox shall notify insite within nbsp insite shall then submit invoice nicox relevant amount payable nicox shall milestone payment within later thirty nbsp nicox notifying insite such occurrence nbsp following receipt such invoice nicox fails amount date insite charge interest outstanding amount rate equivalent basis point above daily libor rate then force table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign that nicox required applicable deduct withhold from amount payable insite shall deducted withheld nicox rate required applicable paid appropriate governmental agency behalf insite nicox shall submit insite reasonable proof payment deducted withheld together with accounting calculation such within thirty nbsp after such remitted proper authority party will font style white space nowrap operate font reasonably completing filing document required under provision applicable under other applicable connection with making required payment withholding payment connection with claim refund credit such payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign avoidance doubt payment under term this agreement expressed inclusive applicable duty applicable country territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign consideration exploitation right granted nicox hereunder nicox shall running royalty royalty insite detailed below table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sale european territory aggregated basis product sale european territory amount equal table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first sale european territory year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion sale european territory which greater than than equal year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion sale european territory which greater than than equal year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion sale european territory which greater than year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other sale territory aggregated basis such product sale territory excluding avoidance doubt european territory amount equal table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign first sale outside european territory year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion sale outside european territory which greater than than equal year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign portion sale outside european territory which greater than year table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject clause product product basis royalty payable sale particular product generated country shall reduced twenty five cent nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign direct generic competitor affected product being marketed human being more third party that country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sale affected product that country decline twenty five cent nbsp more comparing sale affected product quarter following entry direct generic competitor with sale affected product same quarter previous year table style margin margin bottom margin left font size font family time roman following occurrence event described both clause nbsp above royalty affected product affected country shall then payable reduced percentage long there remains direct generic competitor affected country subject clause style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product product basis royalty payable sale particular product generated country shall reduced fifty cent nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign direct generic competitor affected product being marketed human being more third party that country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign sale affected product that country decline fifty cent nbsp more comparing sale affected product quarter following entry direct generic competitor with sale affected product same quarter previous year table style margin margin bottom margin left font size font family time roman following occurrence event described both clause nbsp above royalty affected product affected country shall then payable reduced percentage long there remains direct generic competitor affected country style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty shall payable country country product product basis until latest table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign expiry revocation last existing insite patent pfizer patent expire covering such product including avoidance doubt manufacture sale thereof relevant country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nbsp year from table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case product covered pfizer patent namely specified product first commercial sale such product relevant country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case other product first pricing reimbursement approval product relevant country pricing reimbursement approval sought first regulatory approval product relevant country table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign expiry revocation nicox statutory market exclusivity such product relevant country table style margin margin bottom margin left font size font family time roman payment period style margin margin bottom margin left font size font family time roman purpose this clause direct generic competitor mean third party version product that been designated generic therapeutic equivalent product regulatory authority applicable country territory more specifically europe application been accepted according article generic hybrid directive reference member state mutual recognition decentralised procedure style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign more licence patent licence know extent such licence result from misuse third party know insite agent font style white space nowrap contractor font licensee without prejudice other right remedy nicox from third party required nicox order exploit product field third party patent licence country territory fifty cent nbsp royalty other payment actually paid nicox under such third party patent licence with respect exploitation such product field such country territory shall creditable against royalty from nicox insite with respect sale such product such country provided that case shall such reduction lower amount royalty otherwise payable under clause clause applicable more than fifty cent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding foregoing long insite owes royalty payment under pfizer agreement specified product specified product country country basis royalty from nicox insite with respect sale specified product country shall reduced amount that than amount actually payable insite pfizer under pfizer agreement with respect such specified product such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox shall starting from date first commercial sale product remainder payment period within twenty five nbsp after each quarter case specified product within fifteen nbsp such quarter deliver insite detailed statement product product country country basis showing nbsp sale during such quarter currency which sale were made euro after application exchange rate pursuant clause including setting forth gross amount invoiced deduction taken calculation sale setting forth entity rendering invoice nbsp royalty payable insite under this agreement based foregoing nbsp exchange rate other methodology used converting into euro from other currency which sale were made nbsp disposition product nicox specified reseller other than pursuant sale cash nbsp withholding deducted respect such royalty pursuant clause upon receipt nicox statement insite shall issue invoice reflect royalty payable insite respect quarter royalty payment each quarter shall within nbsp receipt insite invoice relevant payment late payment shall subject interest rate referred clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign period five nbsp year from quarter which particular payment nicox shall keep shall cause specified resellers keep complete accurate record relation sale calculation thereof relation number batch required calculate payment with respect equipment where applicable under clause shall permit insite appointed external accountant visit premise occasion twelve nbsp month period least nbsp month after previous examination revealed material discrepancy reasonable notice examine make copy relevant book record purpose verifying accuracy report made nicox amount paid payable under this clause clause cost such audit shall borne insite except where reveals underpayment greater than three cent table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman which case shall borne nicox without prejudice other remedy result audit book record nicox shown that payment under this agreement were than amount that should have been paid then nicox shall make payment required made eliminate such discrepancy within nbsp business receipt invoice therefor which include interest above rate nicox shall also cause specified resellers permit nicox audit such specified resellers audit their relevant book record purpose nicox verifying accuracy report made such specified resellers amount paid payable addition where reasonably requested pfizer nicox shall permit shall cause pfizer patent licensee permit independent accountant selected pfizer audit nicox such licensee book record pfizer behalf connection with sale specified product same manner same extent that insite required maintain permit audit insite book record with respect such sale under section nbsp pfizer agreement provided that such obligation shall automatically expire once insite obligation under provision section nbsp pfizer agreement expire terminate reason style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign payment contemplated under this agreement shall euro except provided clause which payment shall made dollar shall made wire transfer payment bank account designated receiving party euro shall currency account when calculating sale amount such sale currency other than euro shall converted into euro using average monthly foreign exchange rate relevant currency calendar month during which sale recorded such exchange rate published federal reserve federal reserve statistical release foreign exchange rate available website http federalreserve release current default successor site average exchange rate currency published federal reserve conversion shall made based average closing rate exchange quoted bloomberg successor same time period table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox acknowledges provision section nbsp pfizer agreement regarding estimated monthly sale nicox agrees facilitate compliance with such provision respect specified product nicox further acknowledges that extent nicox delivers information regarding such estimated monthly sale insite further delivery insite pfizer then such further delivery shall constitute breach clause this agreement nicox obligation under this clause shall automatically expire once insite obligation under provision section nbsp pfizer agreement expire terminate reason table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite acknowledges agrees that payment this agreement including payment this clause including payment under clause payment associated with separate agreement entered into party under clause payment associated with clinical trial under clause extent payable insite together with payment hire agreement where applicable clause comprise payment made nicox insite with respect subject matter this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign information table style margin margin bottom margin left font size font family time roman existing background information know style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign later than thirty nbsp following effective date insite shall provide nicox electronic common technical document ectd format table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign know background information insite possession control effective date already nicox possession including following table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign azasite package existing data including prior meeting minute with regulatory authority stability formulation product with specification analytical method table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign bromsite package been prepared existing data including prior meeting minute with regulatory authority stability formulation product with specification analytical method table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other product package existing data including prior meeting minute with regulatory authority stability formulation product with specification analytical method table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign copy data study result other written material comprised within know including material relating clinical clinical development product including trial master file applicable information contained global safety database established maintained insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign disclosure made document delivered insite pursuant clause shall considered confidential information insite table style margin margin bottom margin left font size font family time roman information generated during term style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign without prejudice obligation under clause through insite shall make available nicox minimum each nbsp month during term event promptly upon material know becoming available insite which relevant continuing right obligation party background information know including scientific clinical clinical regulatory manufacturing quality assurance information data constituting background information know generated during term relation product equivalent product insite insite data licensee agent contractor partner insite data solely accordance with right granted nicox under this agreement provided that nbsp insite data shall exclude information data nbsp relating insite improvement except extent provided pursuant provision clause nbsp generated from relating clinical study carried insite that approved study except extent nicox acquires right such information data under clause applicable clause nbsp nicox have right certain insite data under this agreement without entering into separate licence insite shall only required make available nicox summary such data order enable nicox determine whether wish obtain such right under clause applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign without prejudice obligation under clause through nicox shall make available insite minimum each nbsp month during term scientific clinical clinical regulatory manufacturing quality assurance information data including development safety data generated during term relation product nicox nicox agent licensee other agent contractor partner nicox licensed data provided that nbsp nicox licensed data shall exclude information data nbsp relating nicox improvement except extent separate licence entered into party accordance with clause nbsp generated from relating clinical study carried nicox that approved study except extent insite acquires right such information data under clause applicable clause nbsp nicox shall provided clause only required make available insite summary such data order enable insite determine whether wish obtain such right under clause applicable nicox hereby grant insite cost insite royalty free irrevocable perpetual transferable licensable exclusive licence nicox licensed data intellectual property right with respect thereto solely connection with development manufacture distribution other exploitation including right make offer sale sell import product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman field outside territory veterinary application worldwide insite shall entitled disclose nicox licensed data licensed under this clause license such licence insite data licensee other insite licensee their agent contractor partner provided that insite procures that such nicox licensed data used solely development manufacture distribution other exploitation product outside territory field except with adverse event information which shared used globally including with licensee insite data licensee veterinary application worldwide style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign unless otherwise agreed writing between party insite undergoes insite change control then from date such insite change control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provision clause shall continue apply with respect approved study then being undertaken party date such insite change control such clause shall otherwise longer apply with respect other know improvement information data generated during term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provision clause shall longer apply table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provision clause shall longer apply provided that thereafter every twelve nbsp month following effective date nicox shall provide insite written report summarizing effort accomplishment nicox including effort accomplishment through authorized resellers other licensee during preceding twelve nbsp month period developing product territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox shall longer required offer insite nicox improvement made after date insite change control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provision clause shall continue apply only with respect development activity assigned insite prior date insite change control such clause will otherwise cease apply table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox option upon written notice insite collaboration development committee manufacturing committee shall disbanded which case responsibility assumed disbanded committee revert nicox obligation party relation thereto including attendance meeting shall longer apply except follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign avoidance doubt further clinical study that party wish conduct shall conducted accordance with clause without either party having propose study pursuant clause disclose license information data other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox will entitled assume responsibility disbanded committee matter that were subject insite final decision approval authority which matter will revert insite nicox upon disbandment committee which includes avoidance doubt matter related insite patent pfizer patent insite mark other intellectual property right controlled insite except intellectual property right owned owned nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox will entitled assume responsibility disbanded committee that required approval such committee without either party having final decision approval authority requiring unanimous consent which responsibility need approved through disbanded committee will continue require approval both party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party shall commercially reasonable effort enter into safety data exchange agreement between party third party marketing running clinical trial product table style margin margin bottom margin left font size font family time roman compliance with style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall ensure that information data generated behalf supplier complies with applicable rule regulation including applicable good laboratory practice good clinical practice good manufacturing practice other applicable practice such good pharmacovigilance practice good distribution practice table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign collaboration development committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign within thirty nbsp effective date party shall establish governance committee collaboration development committee assist overseeing making recommendation decision relating development regulatory matter relating development collaboration development committee shall comprised nbsp voting member from each respective party each member representing clinical development function other representing business commercial function each party replace member time upon prior written notice other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall designate member chair collaboration development committee such chair shall serve primary point contact between party with respect matter relating this agreement resolve issue disagreement between party needed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign collaboration development committee shall meet frequently than once calendar quarter during period development product until obtaining regulatory approval product each country european territory thereafter least once year least nbsp meeting year shall person remaining meeting conducted telephone videoconference minute meeting shall issued with responsibility taking issuing minute alternating between party person meeting shall alternate between nicox facility insite facility such other location mutually agreed collaboration development committee such date such time agreed collaboration development committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign member from each party their permitted designees must present including presence telephone video conference meeting collaboration development committee such meeting proceed person meeting shall require physical attendance four nbsp member their designees unless otherwise agreed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each member shall permitted send suitable designee place collaboration development committee meeting each party permit expert specialist other appropriate visitor attend meeting collaboration development committee notice other provided that they shall have vote each party shall responsible expense participating collaboration development committee subcommittee thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign chair collaboration development committee shall responsible agreeing agenda each collaboration development committee meeting which shall circulated least nbsp prior each collaboration development committee meeting which shall include copy then current development plan together with proposal made either party amendment table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign collaboration development committee shall have responsibility authority table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign prepare maintain development plan development plan registration each product field territory initial indication following outline appendix additional indication each development plan shall include inter alia scope development including approved study time table budget each development plan amended from time time decision collaboration development committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign oversee provide guidance direction connection with regulatory approval product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign oversee provide guidance direction connection with overall strategy regulatory submission product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provide guidance direction connection with decision party regarding prosecution maintenance enforcement defence insite patent pfizer patent extent permissible under pfizer agreement insite mark territory other intellectual property matter relating territory arising hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign provide guidance safety data exchange between party involved safety data collection regulatory safety reporting product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign discus consider approval study proposed under clause overseeing approved study territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign receive information relating review improvement proposed under clause relation insite improvement consider determine whether they should jointly funded table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign perform such other function party agree writing from time time table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign collaboration development committee shall have authority other than that expressly forth clause otherwise this agreement specifically shall have authority table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amend interpret this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign make decision that inconsistent with express term this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign determine whether party obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign determine whether breach this agreement occurred table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign address dispute disagreement between party with respect payment owed alleged owed party other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign decision collaboration development committee shall made majority vote member following discussion during which member appointed party shall duly consider observation representation made member appointed other party with each member having nbsp vote subject following event majority vote achieved with respect certain decision then insite authorized representative shall meet with nicox authorized representative agreed location telephone discus attempt resolve good faith disagreement within twenty nbsp meeting which such disagreement occurred such officer party unable resolve disagreement then nicox shall have final decision approval authority excluding table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign matter related insite patent pfizer patent insite mark other intellectual property right controlled insite except intellectual property right actually potentially owned owned nicox which insite will have final decision approval authority subject clause provided that insite exercise final table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman decision approval authority without waiting decision collaboration development committee resolution disagreement extent such decision resolution obtained before filing response deadline required with respect such matter provided further that such intellectual property right controlled insite outside territory shall subject provision this clause avoidance doubt oversight guidance collaboration development committee style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign purpose clarification notwithstanding other provision this agreement where party holder regulatory approval sponsor clinical trial where action required applicable regulatory authority such party shall absence agreement collaboration development committee have final relation such action provided that shall reasonably considering interest other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign matter requiring insite spend fund excess amount budget previously approved member both party which insite prior written consent will required table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign matter described this agreement subject final decision approval authority either party requiring unanimous consent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign decision which clinical study shall included with development plan which decision shall where agreed subject process clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign within thirty nbsp effective date party shall establish manufacturing committee manufacturing committee assist overseeing making recommendation decision relating manufacturing regulatory matter relating manufacturing territory manufacturing committee shall comprised voting member from each respective party each member representing function other representing regulatory function each party replace member time upon prior written notice other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall designate member chair manufacturing committee such chair shall serve primary point contact between party with respect matter relating this agreement resolve issue disagreement between party needed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing committee shall meet frequently than once calendar quarter during period development product until obtaining regulatory approval product each country european territory thereafter least once year least nbsp meeting year shall person remaining meeting conducted telephone videoconference minute meeting shall issued with responsibility taking issuing minute alternating between party person meeting shall alternate between nicox facility insite facility such other location mutually agreed manufacturing committee such date such time agreed manufacturing committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign member from each party their permitted designees must present including presence telephone video conference meeting manufacturing committee such meeting proceed person meeting shall require physical attendance four nbsp member their designees unless otherwise agreed table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each member shall permitted send suitable designee place manufacturing committee meeting each party permit expert specialist other appropriate visitor attend meeting manufacturing committee notice other provided that they shall have vote each party shall responsible expense participating manufacturing committee subcommittee thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign chair manufacturing committee shall responsible agreeing agenda each manufacturing committee meeting which shall circulated least nbsp prior each such meeting table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing committee shall have responsibility authority table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign develop execute manufacturing plan clinical commercial supply product field throughout territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign manage supply product field throughout territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign oversee provide guidance direction connection with manufacture product nbsp development field only territory with respect clinical development nbsp distribution field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign identify appoint manufacturer manufacturer manufacture product nbsp development field only territory with respect clinical development nbsp distribution field territory accordance with clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign perform such other function party agree writing from time time table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacturing committee shall have authority other than that expressly forth clause otherwise this agreement specifically shall have authority table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amend interpret this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign make decision that inconsistent with express term this agreement including particular limited provision clause manufacture supply product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign determine whether party obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign determine whether breach this agreement occurred table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign address dispute disagreement between party with respect payment owed alleged owed party other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign decision manufacturing committee shall made majority vote member with each member having nbsp vote subject following event majority vote achieved with respect certain decision then matter shall referred collaboration development committee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign development regulatory table style margin margin bottom margin left font size font family time roman development responsibility style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign save those development related matter which responsibility insite under this agreement pursuant development plan nicox shall responsible cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development product field territory including providing regulatory clinical pharmacovigilance expertise managing pharmacovigilance activity third party supplier auditing supplier involved development compliance with regulatory requirement territory their contractual obligation table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign managing chemistry manufacturing control product supply clinical trial supply field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign managing clinical clinical development activity territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject clause obtaining maintaining throughout term necessary regulatory approval product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign preparing regulatory dossier subject clause filing regulatory submission relating product field territory including conducting clinical trial research collecting necessary data preparing report other documentation required connection with obtaining maintaining regulatory approval product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign communication other dealing with regulatory authority territory relating product field including filing supplement other document with such regulatory authority necessary comply with regulatory requirement territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign responsibility clause shall carried accordance with term development plan decision collaboration development committee every nbsp month following effective date nicox shall provide collaboration development committee written report summarizing effort accomplishment nicox including effort accomplishment through authorized resellers other licensee during preceding month period developing product territory data information generated from relating such activity described clause table style margin margin bottom margin left font size font family time roman regulatory submission style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory submission regulatory approval product field territory shall made held name either nicox third party nicox election case case basis foregoing subject applicable regulation relating application holding regulatory submission regulatory approval product field territory without prejudice requirement manufacturer other applicable third party apply hold such table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign extent permitted applicable insite shall commercially reasonable effort promptly transfer nicox regulatory approval controlled insite country territory formerly covered agreement agreement country shall commercially reasonable effort make available nicox commercially reasonable effort cause relevant third party make available nicox allow nicox make reference otherwise regulatory approval certificate regulatory document relating product including agreement country country outside territory solely accordance with licence under this agreement extent that nbsp they relate useful territory nbsp insite control such regulatory approval certificate regulatory document nbsp such information disclosed used nicox without further payment insite authority third party save extent nicox agrees writing responsible reimburse insite such further payment without limiting foregoing insite will request commercially reasonable effort procure that akorn other relevant licensee contractor insite operates with nicox enable nicox apply certificate pharmaceutical product product nicox foregoing information subject clause term this agreement table style margin margin bottom margin left font size font family time roman insite shall nicox request commercially reasonable effort assist nicox with respect nicox interpretation data relating product field expense nicox nicox requires additional assistance from insite such preparation report attending style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman meeting connection with regulatory submission from time time product product basis nicox require insite perform such service maximum amount below style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign ftes assistance related nbsp nicox interpreting presenting data relating product field made regulatory authority european union nbsp nicox obtaining regulatory approval including requested insite attending meeting with regulatory authority european union table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign ftes assistance connection with nicox discussion with approved manufacturer which required order nicox nbsp obtain regulatory approval product country territory nbsp obtain certificate pharmaceutical product nicox name with respect agreement country table style margin margin bottom margin left font size font family time roman upon receipt request such service from nicox insite shall provide nicox with project plan such service which plan shall include scope service provided maximum amount hour which insite charge complete service upon party agreeing such project plan maximum charge insite will perform service nicox will responsible paying insite such service service performed insite outlined above shall charged rate hour subject agreed pocket cost incurred insite including cost transport accommodation related meeting travel will paid nicox insite service will limited calendar year basis more than ftes service under clause nbsp above ftes service under clause nbsp above style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite nicox shall consult over agree acting reasonably formulation product field territory order satisfy applicable regulatory requirement territory within three nbsp month formulation being agreed insite shall supply final formulation detail specification method analysis stability packaging data nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite shall commercially reasonable effort assist nicox manufacturer polycarbophil obtaining necessary data required shall requested nicox commercially reasonable effort make filing with applicable regulatory authority territory polycarbophil approval novel excipient whether part regulatory approval product applicable separate filing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite shall commercially reasonable effort continue complete nbsp development activity which responsibility insite under development plan provided that activity assigned insite under development plan without insite prior written consent nbsp pharmaceutical clinical development activity relating product equivalent product forth appendix every nbsp month following effective date insite shall provide collaboration development committee written report summarizing effort accomplishment insite during preceding month period such activity development relating thereto insite shall further promptly provide nicox copy data information generated from relating such activity described clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party agree collaborate minimise duplication their effort where possible relation development regulatory matter table style margin margin bottom margin left font size font family time roman clinical study style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign from time time during term party wish conduct allow third party such party behalf conduct additional clinical study relation product field being study additional then existing approved study already provided then existing table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman development plan clarity whether such additional study conducted inside outside territory such party shall submit clinical trial design collaboration development committee approval collaboration development committee approves such clinical study without either party having final decision approval authority pursuant clause such study shall thereby become approved study cost such approved study shall borne party requesting clinical study except provided clause except where collaboration development committee unanimously without either party having final decision approval authority pursuant clause decides that cost approved study shall borne otherwise part approval process collaboration development committee will create further development plan extent relates territory such approved study each party shall consider good faith other party comment concern regard proposed clinical study style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign collaboration development committee approve additional clinical study submitted approval pursuant clause then proposing party proceed with such study inside territory proposing party nicox outside territory proposing party insite independently other party other party will have right information data from such independent study conducted proposing party improvement regulatory approval resulting therefrom unless party acquires right under clause applicable clause except that adverse event information used globally both party each party shall promptly provide other adverse event information accordance with clause through table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign where collaboration development committee determines without either party having final decision approval authority pursuant clause that approved study shall performed intended both european regulatory submission product field such approved study clinical site europe provided that more than fifty cent nbsp site such study will europe unless otherwise agreed party each party will fifty cent nbsp external cost running approved study except that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign external cost nicox fifty cent nbsp overall external cost running entire study greater than estimated cost running equivalent study europe only nicox instead sole discretion contribute approved study amount equal estimated cost running equivalent study europe only with balance paid insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox reasonably determines after considering economic viability proposed approved study nicox taking into account cost approved study light sale potential product concerned relevant market territory that commercially viable nicox commit above payment contribution approved study nicox shall notify insite party shall negotiate reduced payment contribution made nicox participate such approved study with balance paid insite provided that party agree upon such reduced payment contribution then such study shall cease approved study party proceed with such study their respective territory provided clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign timeline approved study will significantly longer than equivalent study performed europe only then nicox shall notify insite party shall negotiate regarding whether reduced payment contribution should made nicox participate such approved study provided that party agree upon such reduced payment contribution then such study shall cease approved study party proceed with such study their respective territory provided clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall promptly provide other party information data approved study conducted connection with product equivalent product including improvement resulting therefrom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such information data controlled insite excluding insite improvement will deemed insite technology included right granted insite nicox under clause such insite improvement will subject provision clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign with respect such information data controlled nicox excluding nicox improvement nicox hereby grant insite royalty free irrevocable perpetual transferable licensable exclusive licence such information data connection with development manufacture distribution other exploitation including right make offer sale sell import product field outside territory veterinary application worldwide provided that such information data disclosed insite licensee other than insite data licensee table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign with respect information data which comprise nicox improvement insite shall have right nicox improvement unless until agreed pursuant separate licence entered into between party accordance with clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign without prejudice foregoing nbsp each party shall inform other party regulatory approval granted such party relation product equivalent product field outside territory with respect insite obligation inside territory with respect nicox obligation nbsp extent that such regulatory approval granted based approved study nicox shall entitled such regulatory approval controlled insite support regulatory submission regulatory approval product field territory pursuant right granted under clause subject clause case regulatory approval relating insite improvement nbsp extent that such regulatory approval granted based approved study based nicox improvement insite shall entitled such regulatory approval controlled nicox support regulatory submission regulatory approval product field outside territory excluding regulatory submission regulatory approval made insite licensee that insite data licensee provided neither party will entitled regulatory approval controlled other party extent such regulatory approval based clinical study that approved study unless party acquires right information data such clinical study under clause improvement relating such study under clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign clinical study conducted party connection with product field that approved study each party will promptly provide other party with summary information data such study improvement regulatory approval resulting therefrom together with statement total amount external cost running such study other party desire table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign information data such study excluding improvement regulatory approval excluding regulatory approval relating improvement notifying first party paying first party fifty cent nbsp external cost running such study which event upon receipt such payment such study will thereafter treated approved study such information data such study such regulatory approval resulting therefrom shall shared used provided clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite improvement related regulatory approval resulting from such study insite improvement related regulatory approval will only included right granted insite nicox under clause extent provided pursuant provision clause under separate licence entered into pursuant clause subject only upon receipt payment nicox amount specified clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox improvement related regulatory approval resulting from such study insite nicox will need negotiate separate licence accordance with clause table style margin margin bottom margin left font size font family time roman initial indication style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign initial indication which party intend develop product territory effective date listed appendix collaboration development committee shall reassess initial indication following discussion between party opinion leader regulatory authority territory agree amend list initial indication avoidance doubt nicox shall required develop particular product specific initial indication listed appendix shall have final initial indication which each product developed territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party will collaborate good faith without obligation through collaboration development committee without either party having final decision approval authority pursuant clause identify evaluate appropriate develop product additional indication field other than initial indication those initial indication amended pursuant clause additional indication table style margin margin bottom margin left font size font family time roman improvement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subject informing collaboration development committee either party make improvement product field insite shall have right nicox improvement unless until agreed pursuant separate licence entered into between party accordance with clause avoidance doubt case where nicox made improvement product nicox shall continue make payment insite under clause during payment period respect such product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign where improvement made ownership intellectual property right such improvement will determined follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign improvement funded solely party such party shall owner intellectual property right such improvement other party agrees transfer assign hereby transfer assigns without further compensation entire right title interest throughout world intellectual property right arising from improvement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign both party share funding improvement both party shall joint owner intellectual property right therein cost prosecution such joint intellectual property shared equally party subject right granted under express provision this agreement each party shall have right practice exploit such jointly owned intellectual property right without obligation account other profit obtain approval other party license assign otherwise exploit such jointly owned intellectual property right reason joint ownership thereof each party hereby waif right have table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman under jurisdiction require such approval accounting extent there applicable that prohibit such waiver each party will deemed consent each party agrees named party necessary bring maintain lawsuit involving such jointly owned intellectual property right avoidance doubt purpose payment period further royalty other compensation shall payable nicox respect jointly owned intellectual property right other than those royalty other compensation clause style margin margin bottom margin left font size font family time roman each party agrees promptly execute other instrument form assignment other document take such further action other party reasonably request order give effect evidence foregoing assignment each party will notify other promptly following development improvement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign without limiting other right party herein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign where nicox sole owning party intellectual property right improvement nicox improvement requested insite nicox insite shall negotiate good faith agree term including royalty licence such nicox improvement intellectual property right related regulatory approval with respect thereto connection with development manufacture distribution other exploitation including right make offer sale sell import product field outside territory veterinary application worldwide agreed relation other product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign where party joint owner intellectual property right improvement requested insite nicox insite shall negotiate good faith agree term including royalty exclusive licence such joint improvement intellectual property right related regulatory approval with respect thereto connection with development manufacture distribution other exploitation including right make offer sale sell import product field outside territory veterinary application worldwide agreed relation other product provided that insite shall given credit equal amount funding contribution against payment made under such licence table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite technology licensed nicox pursuant clause will include insite patented improvement created within five nbsp year effective date respect insite patented improvement created after such date summary shall provided nicox accordance with clause requested nicox nicox insite shall negotiate good faith agree term including royalty licence nicox such insite patented improvement which licence shall substantially equivalent term those this agreement except time period such licence economic term including royalty which shall based solely inherent value insite patented improvement provided that avoidance doubt consistent with clause such licence further payment shall required order nicox exploit otherwise jointly owned improvement exclusive basis table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite technology licensed nicox pursuant clause will include insite patented improvement during payment period time prior expiration payment period nicox request insite patented improvement after payment period which case nicox insite shall negotiate good faith agree upon separate licence agreement nicox such insite patented improvement intellectual property right with respect thereto following expiry payment period which licence shall substantially equivalent term those this table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman agreement except time period such licence economic term including royalty which shall based solely inherent value insite patent improvement provided that avoidance doubt consistent with clause such licence further payment shall required order nicox exploit otherwise jointly owned improvement exclusive basis style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign extent party unable agree term including royalty licence nicox improvement insite patented improvement insite patented improvement applicable pursuant clause within commencement negotiation term such licence then either party written notice other party invoke arbitration procedure clause nbsp baseball arbitration procedure determine such term table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign baseball arbitration procedure shall managed independent expert selected jointly party party agree expert selection within nbsp calendar invocation baseball arbitration procedure appointed then current president pharmaceutical research manufacturer america phrma table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign baseball arbitration procedure shall comprise accordance with procedure determined expert each party preparing written report setting forth final position with respect proposed term expert then selecting nbsp party position final decision provided that unless party otherwise agree each party position with respect licence insite improvement must substantially equivalent term those this agreement except nbsp time period such licence nbsp economic term including royalty party agree that economic term including royalty will based inherent value relevant insite improvement shall clarity exclude factor such cost nicox altering product manufacturing process clarity expert selects insite position nicox shall have discretion whether enter into licence insite improvement nicox enter into licence nicox will cease using insite improvement promptly following later expert determination date which right such improvement without additional consideration under this agreement expire table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign expert shall have authority render substantive decision other than select position either nicox insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party shall reasonable effort procure that baseball arbitration procedure completed within sixty nbsp calendar being invoked table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party shall share equally cost baseball arbitration procedure including cost independent expert excluding avoidance doubt each party cost including legal cost respect baseball arbitration procedure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clarity where above procedure been invoked nicox shall entitled relevant improvement pending expert decision subject subsequent payment which nicox elect enter licence shall nevertheless payable nicox during such period table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite will provide nicox with prompt written notice insite acquires seeking acquire right third party patent controlled third party other than insite data licensee covering manufacture sale product field territory third party patent provided however that insite will under obligation obtain such licence from table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman such third party such licence third party patent territory insite acquires right third party patent field territory such third party patent will deemed included licence insite technology that granted nicox pursuant clause this agreement nicox following style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within receiving notice licence third party patent nicox confirms that will accept licence licence third party patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox agrees payment including front licence royalty maintenance patent prosecution cost payable third party respect licence field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite shall reasonable endeavour ensure that nicox disadvantaged compared insite other licensee insite with respect amount additional payment royalty that would payable third party respect licence third party patent field territory apportionment such payment nicox table style margin margin bottom margin left font size font family time roman complaint adverse event reporting style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall maintain record complaint adverse event receives with respect product required applicable regulatory requirement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall notify other party reasonable detail complaint received relating product later than seventy nbsp hour after receiving complaint other timeframe relevant agreed safety data exchange agreement event sufficient time allow other party comply with regulatory requirement other requirement imposed upon jurisdiction which product being marketed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall maintain safety database relating product accordance with regulatory requirement each party shall share information with other accordance with relevant agreed safety data exchange agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign where reasonably possible each party shall consult with other prior communication with regulatory authority regarding complaint adverse event relating product except where other party agrees writing with first party that such consultation required event shall inform other promptly after such communication detail table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign where either party submits adverse event report relating product regulatory authority including during clinical trial they shall provide copy final report other party within twenty four nbsp hour submission regulatory authority table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall promptly provide other party relevant information relation product that could relevant safety quality efficacy claim product irrespective indication which relates table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall submit local regulatory authority where holder relevant regulatory approval product concerned complaint adverse event according local regulatory requirement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign manufacture supply product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign later than hundred eighty nbsp after effective date time thereafter request party party shall acting through manufacturing committee then current manufacturer most suitable supplier manufacturing service product territory taking into consideration manufacturing price product quality term supply regulatory requirement territory criterion regulatory approval territory other matter that manufacturing committee considers relevant manufacturing committee decides based above that current manufacturer most suitable table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman manufacturer nicox product territory nbsp shall identify more suitable alternative manufacturer product later than ninety nbsp after such determination nbsp such decision manufacturing committee made majority vote without either party exercising final decision approval authority pursuant clause cost assessing selecting appointing third party manufacturer shall shared equally party nbsp such decision manufacturing committee made nicox exercising final decision approval authority pursuant clause cost assessing selecting appointing third party manufacturer shall initially borne nicox provided that insite subsequently approved manufacturer within five nbsp year from such appointment manufacture product equivalent product insite shall reimburse nicox amount equal fifty cent nbsp cost incurred nicox relation appointment establishment approved manufacturer including cost associated with technology transfer referred clause plus fifteen cent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox will contract directly with third party manufacturer approved manufacturing committee pursuant clause approved manufacturer which avoidance doubt current manufacturer manufacturing committee decides manufacture supply product territory connection therewith insite shall provide nicox with such assistance nicox reasonably require relation entry into such contract including providing reasonable assistance request that product whether supplied distribution development made available nicox from approved manufacturer cost greater than cost product equivalent product insite subject cost increase arising result adaptation required regulatory approval product territory notwithstanding foregoing insite liability nicox approved manufacturer nicox fail conclude manufacturing agreement except extent arising from breach insite this clause manufacturing agreement concluded omission approved manufacturer under connection with that agreement insite acknowledges that nicox right license insite technology approved manufacturer purpose manufacturing product anywhere world nbsp development field only territory with respect clinical development nbsp distribution field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party agree collaborate minimise cost manufacture product territory either party identifies opportunity improve manufacture identifies alternative manufacturer shall promptly inform other party table style margin margin bottom margin left font size font family time roman technology equipment transfer approved manufacturer style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign approved manufacturer current manufacturer insite shall provide approved manufacturer with such background information know necessary manufacture product distribution field territory including necessary regulatory dossier product territory analytical procedure batch record shall effect technology transfer from insite manufacturer approved manufacturer designated manufacturing site further insite shall commercially reasonable effort assist nicox ensuring that regulatory approval approved manufacturer with respect manufacturing product territory obtained quickly possible external cost such technology transfer including transport accommodation cost reasonably incurred insite will allocated between party same cost selecting approved manufacturer pursuant clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign approved manufacturer current manufacturer following identification approved manufacturer insite will inform nicox whether insite will permit approved manufacturer custom manufacturing equipment such permission unreasonably withheld delayed insite permit such insite shall nicox request table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman hire custom manufacturing equipment nicox connection with manufacturing product approved manufacturer designated manufacturing site during term under financial condition forth this clause hire agreement such event within thirty nbsp nicox written request insite shall deliver install custom manufacturing equipment approved manufacturer designated manufacturing site insite reasonable cost delivering installing custom manufacturing equipment detailed above shall allocated between party same cost selecting approved manufacturer pursuant clause applicable nicox shall insite hire custom manufacturing equipment amount equal seven thousand five hundred nbsp batch excluding equipment nicox shall starting from first custom manufacturing equipment subject earlier termination hire agreement remainder term within five nbsp each month deliver insite detailed statement showing number batch created using custom manufacturing equipment upon receipt nicox statement insite shall issue invoice reflect equipment payable insite respect month equipment shall payable insite within nbsp receipt insite invoice relevant payment custom manufacturing equipment shall time remain property insite nicox shall have right title interest custom manufacturing equipment save right possession custom manufacturing equipment subject term condition this agreement risk loss theft damage destruction custom manufacturing equipment shall remain with insite provided that nicox terminate hire agreement event such loss theft damage destruction nicox terminate hire agreement time upon notice insite upon termination hire agreement reason insite shall arrange custom manufacturing equipment collected returned possession nicox shall account insite unpaid equipment style margin margin bottom margin left font size font family time roman second contract manufacturer style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign without prejudice nicox right procure product from approved manufacturer nicox discretion sole cost manufacture have manufactured third party second contract manufacturer place approved manufacturer some nicox requirement product concerned product distribution field territory development field only territory with respect clinical development insite acknowledges that nicox right license insite technology second contract manufacturer purpose manufacturing product anywhere world nbsp development field only territory with respect clinical development nbsp distribution field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox shall responsible managing manufacturing activity obtaining regulatory approval second contract manufacturer respect territory shall bear manufacturing expense product territory using second contract manufacturer table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox appoints second contract manufacturer insite shall provide second contract manufacturer with such background information know necessary manufacture have manufactured product distribution field territory including necessary regulatory dossier product territory analytical procedure batch record shall effect technology transfer from insite manufacturer second contract manufacturer designated manufacturing site nicox shall external cost associated with technology transfer including transport accommodation reasonably incurred insite subject receipt evidence expenditure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite wish subsequently second contract manufacturer within five nbsp year from such second contract manufacturer appointment manufacture product equivalent product such second contract manufacturer enters into agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman with insite otherwise manufacture product equivalent product insite within such five nbsp year period insite shall nicox amount equal fifty cent nbsp investment start cost incurred nicox relation appointment establishment second contract manufacturer including cost associated with technology transfer referred clause plus fifteen cent nicox shall provide insite with such assistance insite reasonably require relation entry into agreement with second contract manufacturer including providing reasonable assistance request that product equivalent product whether supplied distribution development made available insite from second contract manufacturer cost greater than cost product nicox subject cost increase arising result adaptation required regulatory approval product outside territory notwithstanding foregoing nicox liability insite second contract manufacturer insite fail conclude manufacturing agreement except extent arising from breach nicox this clause manufacturing agreement concluded omission second contract manufacturer under connection with that agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign commercialisation obligation nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox shall responsible commercialisation directly through third party product territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox shall commercially reasonable effort launch exploit product field each country european territory provided that although nicox intention sell product directly least some country thereof avoidance doubt exploit product european territory part thereof through authorized resellers following regulatory approval applicable country territory pricing reimbursement approval where such required desirable exploit product such commercially reasonable effort shall reflect commercial potential product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign country territory other than european territory country european territory where nicox decided exploit product through authorized resellers nicox shall commercially reasonable effort place appropriate agreement with third party launch exploit product field such commercially reasonable effort shall reflect commercial potential product such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox shall through collaboration development committee seek maximise potential level pricing reimbursement territory with clinical indication pursued comparator used clinical trial product format table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox notified insite that voluntarily other than result regulatory matter cause beyond reasonable control elected launch product following pricing reimbursement approval elected discontinue marketing product country territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox fails launch exploit have launched exploited product field table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign country european territory within nbsp after pricing reimbursement approval such country pricing reimbursement approval required desirable sell product that country nbsp after regulatory approval such country pricing reimbursement approval required desirable sell product that country table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign country territory that european territory within nbsp following pricing reimbursement approval pricing reimbursement approval required desirable sell product that country nbsp following regulatory approval such country pricing reimbursement approval required desirable sell product that country table style margin margin bottom margin left font size font family time roman then case clause right granted nicox under this agreement relation that product respect affected country only will upon notice insite revert insite without further consideration nicox case clause than ninety nbsp prior expiration relevant period nicox will required demonstrate insite what step nicox taken launch exploit have launched exploited product that country well provide plan exploitation product that country during following nbsp month period such further nbsp month period nicox still launched exploited procured launch exploitation product that country then right granted nicox under this agreement relation that product respect affected country will revert insite without further consideration nicox except nicox negotiation with appointed distributor such right shall revert insite unless further ninety nbsp elapses without product having been launched exploited country concerned furtherance thereof where right revert insite under this clause then this agreement shall deemed terminated with respect affected product affected country only provision clause shall apply with respect such affected product such affected country right granted nicox respect affected product relation other country territory shall continue full force effect style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign obligation nicox with respect product under this clause expressly conditional upon continuing absence adverse event relating safety lack efficacy product nicox option suspend exploitation such product such period nicox considers acting reasonably that such condition event continues exist table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign every nbsp month following effective date nicox shall provide insite written report summarizing product product country country basis country europe forth appendix summary material development country remaining three region eastern europe middle east africa forth appendix region region basis effort accomplishment nicox including nbsp effort accomplishment through authorized resellers other licensee nbsp notification regulatory approval product launch status during preceding month period launching exploiting product territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign product recall withdrawal quarantine table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory authority table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign threatens initiate action against party suspend revoke withdraw vary regulatory approval product equivalent product from market regulatory jurisdiction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign requires party licensee distributor distribute dear doctor letter equivalent regarding product equivalent product regulatory jurisdiction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign threatens requires party licensee distributor withdraw recall batch product equivalent product table style margin margin bottom margin left font size font family time roman affected party shall notify other party such event within twenty four hour after affected party becomes aware action threat requirement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign regulatory authority anywhere world provides notice party that such regulatory authority challenge query safety efficacy product equivalent product query whether risk benefit balance product equivalent product positive under normal condition affected party shall provide other party within three nbsp calendar discussion correspondence with regulatory authority copy correspondence transcript discussion english applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign confidential information table style margin margin bottom margin left font size font family time roman nondisclosure obligation style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign during term thereafter until such information fall within exception under clause each party will maintain confidential information other party trust confidence will disclose confidential information other party third party confidential information other party except extent required enjoy right comply with obligation under this agreement including avoidance doubt surviving right obligation subject express provision this clause confidential information shall disclosed only employee agent affiliate authorized resellers licensee licensee subject express restriction this agreement professional adviser consultant contractor actual potential partner investor lender only those above have need reasonable desire such information bound obligation nondisclosure least restrictive those forth herein regulatory authority connection with regulatory approval product equivalent product each party shall responsible disclosure confidential information such employee agent affiliate authorized resellers licensee licensee professional adviser consultant contractor partner investor lender each party shall protect other party confidential information using than same standard care with which treat confidential information time shall least reasonable care insite acknowledges interest nicox exclusive distributor licensee product territory maintaining confidentiality relation thereto insite accordingly agrees that insite technology confidential nature that material nicox exploitation product territory shall disclosed insite third party except those listed above subject same condition extent such insite technology also relates other product reasonably required connection with their exploitation clarity provision clause shall apply foregoing sentence table style margin margin bottom margin left font size font family time roman exception style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign obligation this clause shall apply with respect portion confidential information that receiving party show competent written proof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign lawfully becomes generally known available public through fault receiving party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign known receiving party time receiving such information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign hereafter lawfully furnished receiving party third party matter right without restriction disclosure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign independently developed receiving party without confidential information without other breach this clause evidenced written record table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject written permission disclose provided disclosing party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman authorized disclosure style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding other provision this agreement each party disclose confidential information other party such disclosure required nbsp order court other governmental authority arbitral panel with jurisdiction over disclosing party nbsp regulation including without limitation comply with regulatory requirement applicable stock exchange disclosure requirement only extent that such disclosure necessary with respect disclosure under clause party being required make disclosure shall give much written notice legally practically possible other party hereto shall have made commercially reasonable effort obtain protective order requiring that confidential information disclosed used only purpose which order issued shall operate with other party minimize scope content such disclosure with respect disclosure under clause party being required make disclosure shall first give written notice other party hereto shall extent practicable allow other party sufficient time comment content such disclosure shall consult with other party with respect comment such other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign addition insite disclose pfizer during term pfizer agreement nbsp copy this agreement required under section nbsp pfizer agreement nbsp report provided nicox insite hereunder required under pfizer agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite warrant represents nicox effective date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign exclusive legal beneficial owner right title interest existing insite patent insite mark durasite technology know background information existing effective date table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign lawful licensee pfizer patent existing effective date forth appendix pfizer patent make claim relevant product other than specified product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign appendix appendix patent controlled insite effective date which cover manufacture sale product durasite technology field territory insite knowledge such patent comprise patent required manufacture distribute product durasite technology field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite right grant nicox right licence described this agreement granted other right licence inconsistent therewith table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign agreement been terminated confers further right that conflict with right granted nicox this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except forth appendix appendix knowledge insite having made reasonable diligent enquiry product were subject regulatory approval regulatory submission application regulatory approval regulatory submission have been filed other agreement country respect such other agreement country knowledge insite agreement require nicox actual proposed licensee distributor make payment other third party present obstacle those country connection with exploitation product table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign relation insite technology owned third party licensed insite including pfizer patent insite complies material respect with term relevant licence agreement with third party owner except where failure comply would reasonably expected materially adversely affect right licensed nicox hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign relation debenture acceptance credit overdraft loan other financial facility outstanding available insite neither continuation cessation default term condition such facility will would reasonably expected materially adversely affect right licensed nicox hereunder insite knowledge circumstance exist relation such facility which would reasonably expected table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except forth appendix knowledge insite exploitation product accordance with this agreement infringe intellectual property right third party insite received written notice otherwise have knowledge such claim ground such claim infringement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except forth appendix there interference opposition pending knowledge insite threatened against insite whether before regulatory authority court administrative office agency which relate existing insite patent insite mark knowledge insite there such interference opposition pending threatened which relate pfizer patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except forth appendix knowledge insite none existing insite patent insite mark pfizer patent invalid unenforceable insite received written notice allegation proceeding pending knowledge insite threatened which challenge existing insite patent insite mark pfizer patent whether validity enforceability otherwise table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except forth appendix extent notified insite nicox writing prior effective date knowledge insite none intellectual property right insite technology being infringed third party territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign knowledge insite there material information controlled insite with respect safety quality performance product there material scientific technical fact data controlled insite relating product that have been disclosed writing nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign knowledge insite conception development reduction practice existing insite patent durasite technology know pfizer patent constituted involved misappropriation trade secret other intellectual property right third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign knowledge insite nbsp regulatory submission controlled insite with respect product field prepared process being prepared have been prepared filed accordance with regulatory requirement applicable regulatory authority with whom such submission made applicable such country which such submission made nbsp information contained therein true complete accurate prescribed format insite received written notice which reasonably should have insite believe that regulatory submission filed behalf insite with respect product field valid unlikely achieve positive approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign knowledge insite having acted without negligence relation inter alia without limitation contracting with supervision third party concerned research development activity carried third party relation product have been undertaken accordance with good laboratory practice good manufacturing practice good clinical practice appropriate activity undertaken insite itself relation product were required conducted accordance with good laboratory practice good manufacturing practice good clinical practice were undertaken using skill care table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign purpose clause phrase insite knowledge knowledge insite shall construed mean actual knowledge officer insite having responsibility matter matter that subject statement after inquiry provided that insite shall required perform independent freedom operate analysis with respect intellectual property right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite undertakes that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign during term insite will grant right licence inconsistent with right licence granted nicox under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign relation pfizer patent other insite technology owned third party licensed insite during term insite will comply material respect with term relevant licence agreement with third party owner except where failure comply would reasonably expected materially adversely affect right licensed nicox hereunder will anything which result early termination relevant licence agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign relation other intellectual property right owned third party that relates product connection with negotiation acquire licence such intellectual property right connection with product equivalent product insite will commercially reasonable effort obtain right under each such licence agreement license such intellectual property right nicox during term thereafter accordance with clause under term licence this agreement insite shall promptly notify nicox insite procures right itself that licensable nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite will commercially reasonable effort carry action follow nicox instruction relation activity part appendix similar action activity respect agreement country including particular having correspondence signed document executed duly authorised officer official notepaper requested nicox form suggested nicox cost preparation such correspondence document payable regulatory authority agreement country relation product shall sole account nicox provided that insite received nicox prior written consent cost which requires nicox reimburse result this provision insite shall indemnify nicox demand respect payment liability resulting from claim other person making claim connection with agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite will reasonable effort enforce insite right under termination agreement between insite benefit nicox request direction reasonable cost nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation warranty nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox warrant represents insite effective date that term this agreement violate existing obligation contract nicox nicox undertakes that during term nicox shall enter into obligation contract which would violate term condition this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign save expressly this agreement nicox shall cost expense that nicox incurs carrying obligation under this agreement shall have right reimbursement thereof from insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox shall comply material respect with rule regulation applicable performance under this agreement including regulatory requirement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox affiliate shall directly indirectly challenge induce third party challenge validity enforceability pfizer patent patent claim therein initiate participate examination other proceeding related validity enforceability patentability claim pfizer patent before tribunal patent office insite terminate this agreement clause this clause shall give rise such right respect nicox affiliate responding subpoena process discovery request litigation administrative proceeding provided that nicox give prompt notice insite pfizer receipt said subpoena process discovery request nicox shall procure that authorized reseller other licensee shall agree provision substantially same term contained this clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign representation both party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party represents warrant other party effective date that table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign execution delivery performance transaction contemplated hereby have been duly validly authorized that entity good standing jurisdiction with full power ability authority enter into this agreement carry obligation hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign consent approval order authorization registration qualification designation declaration filing with federal state local governmental authority required part such party connection with valid execution delivery performance this agreement except where failure obtain foregoing would individually aggregate reasonably expected materially adversely affect such party ability consummate transaction contemplated herein perform obligation hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign this agreement legal valid obligation binding upon such party enforceable accordance with respective term except such enforceability limited bankruptcy insolvency reorganization moratorium similar table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party hereto agrees execute document such other reasonably necessary perform obligation under this agreement carry purpose intent this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnification insurance damage table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size each party indemnifying party agrees indemnify defend hold harmless other party officer director employee agent indemnified party from against damage liability cost expense including reasonable attorney cost litigation collectively loss awarded against directly incurred paid indemnified party result claim made third party extent resulting from nbsp material breach indemnifying party warranty obligation under this agreement including appendix hereto nbsp fraud negligence wilful misconduct indemnifying party exercise right performance obligation under this agreement nbsp with respect nicox obligation indemnifying party development distribution other table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign exploitation product nicox affiliate nicox agent authorized resellers other licensee excluding loss extent resulting from nbsp claim that practice insite technology infringes misappropriates intellectual property right third party nbsp fraud negligence wilful misconduct insite affiliate their employee agent contractor nbsp with respect insite obligation indemnifying party development distribution other exploitation product equivalent product insite affiliate agent distributor licensee outside territory excluding loss extent resulting from fraud negligence wilful misconduct nicox affiliate their employee agent contractor table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign indemnity given indemnifying party clause conditional upon indemnified party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign promptly notifying indemnifying party writing claim which indemnity based which indemnified party becomes aware provided however that failure give such notice will affect indemnification provided hereunder except extent indemnifying party shall have been actually prejudiced result such failure table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign giving indemnifying party control defence such claim related settlement negotiation subject clause below provided that indemnified party shall have right participate defence such claim related settlement negotiation employ counsel expense separate from counsel employed indemnifying party provided further that under applicable standard professional conduct conflict interest exists between indemnifying party indemnified party respect such claim such indemnified party shall have right employ separate counsel which shall reasonably satisfactory indemnifying party represent such indemnified party with respect matter which conflict interest exists that event reasonable expense such separate counsel shall paid such indemnifying party provided further that indemnifying party shall only responsible reasonable expense separate counsel such indemnified party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign indemnified party will agree settlement such claim that indemnifying party recommend that term obligates indemnifying party full amount loss whether through settlement otherwise connection with such claim unconditionally irrevocably release indemnified party completely from liability connection with such claim provided however that without indemnified party prior written consent indemnifying party shall consent settlement including consent entry judgment that indemnified party refuse good faith agree such settlement that provides injunctive other monetary relief affecting indemnified party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign providing indemnifying party with such assistance information authority reasonably necessary accordance with clause indemnifying party reasonable expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign taking reasonable step mitigate loss damage liability expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign without limiting clause each party shall take from effective date during term maintain product liability insurance public liability insurance with reputable insurance company amount least million million aggregate shall provide other party with certificate insurance from insurer confirming hold such insurance request each renewal such policy extent that such policy invalidated reason insured party shall effect equivalent policy promptly table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subject clause except circumstance gross negligence intentional misconduct party with respect indemnification claim under this clause with respect breach clause neither party shall liable special indirect incidental punitive consequential damage including harm business goodwill lost profit arising from relating this agreement breach thereof whether contract warranty negligence tort strict liability otherwise regardless notice possibility such damage table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nothing this agreement limit excludes party liability other table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign death personal injury arising negligence table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign fraud fraudulent misrepresentation criminal tort deceit table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign where such limitation exclusion would contrary applicable table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign intellectual property table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite shall cost prepare file prosecute maintain nbsp each insite patent within territory nbsp extent insite permitted under pfizer agreement each pfizer patent within territory pfizer patent with respect which insite such right pfizer prosecution patent provided however that insite determine sole discretion prosecution maintenance strategy related insite patent pfizer prosecution patent subject clause notwithstanding foregoing insite shall diligently prosecute maintain insite patent pfizer prosecution patent subject right intentionally cease such prosecution maintenance after notice nicox accordance with this clause nicox shall nicox expense provide assistance reasonably requested insite connection with preparation filing prosecution maintenance insite patent pfizer prosecution patent territory insite shall promptly give notice nicox grant lapse revocation surrender invalidation abandonment insite patent pfizer prosecution patent within territory insite shall give notice nicox desire cease prosecution maintenance insite patent pfizer prosecution patent other than favour continuing application based such parent application country country basis territory such case with respect such insite patent insite mark that relates product with respect such pfizer prosecution patent that relates product extent that insite provide such right nicox under pfizer agreement shall permit nicox sole discretion subject term pfizer agreement applicable continue prosecution maintenance such insite patent pfizer prosecution patent nicox expense nicox elect continue prosecution maintenance insite patent file insite patent based insite election file insite shall execute such document perform such insite expense reasonably necessary effect assignment such insite patent nicox timely manner allow nicox continue such prosecution maintenance insite patent assigned shall considered insite patent hereunder subject foregoing exercise nicox this option shall affect other provision this agreement which remain full force effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size except otherwise provided separate agreement with nicox nbsp provision clause will apply insite improvement even extent within definition insite patent nbsp insite shall free determine sole discretion whether file patent covering insite improvement inside outside territory nbsp insite obligation prosecute maintain patent covering insite improvement inside outside territory except that nbsp insite shall promptly disclose nicox patent filing outside territory respect such insite improvement nbsp upon nicox request sole discretion table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign insite nicox sole expense will file patent application based thereon territory insite nicox sole expense will prosecute maintain patent covering insite improvement where nbsp patent application covering insite improvement have been filed inside outside territory then insite will determine consultation with nicox taking reasonable account nicox observation prosecution maintenance strategy related insite improvement nbsp where patent application covering insite improvement have been filed inside territory only nicox will determine prosecution maintenance strategy related insite improvement each case subject clause until earlier expiration payment period such time separate licence negotiated nicox with insite relation such improvement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign either party becomes aware that third party infringing infringing insite technology infringement territory that third party claim that such insite technology territory invalid unenforceable infringes intellectual property right third party challenge will promptly notify other party thereof including available evidence infringement detail claim invalidity unenforceability infringement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite option shall have first right obligation take step enforce defend insite technology territory insite sole cost against infringement challenge provided that insite shall request reasonably consider nicox representation comment consideration relation such infringement challenge insite decision whether appropriate pursue enforcement effort related such infringement challenge nbsp nicox reasonable opinion insite fails take appropriate step enforce defend insite technology territory within sixty nbsp after date which either party notifies other party applicable infringement challenge nbsp applicable infringement challenge minimis adverse product field territory then nicox shall have right obligation sole expense enforce prosecute such insite technology with respect such infringement challenge including initiation suit proceeding other legal action with respect thereto counsel choice reasonably acceptable insite provided that nicox shall request reasonably consider insite representation comment consideration relation such infringement challenge nicox decision whether appropriate pursue enforcement effort related such infringement challenge insite shall have right expense represented such suit proceeding action counsel choice table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notwithstanding provision clause provision this clause shall apply infringement challenge that relates pfizer patent with respect such infringement challenge that relates pfizer patent applicable infringement challenge minimis adverse product field territory upon nicox request insite shall submit pfizer notice writing approved nicox evidencing such infringement challenge shall request that pfizer assert pfizer patent restrain such infringement insite shall keep nicox informed with respect such proceeding instituted pfizer extent that insite permitted assert pfizer patent under pfizer agreement subject term condition pfizer agreement between insite nicox nbsp insite shall have first right obligation same manner provided clause with respect other insite technology nbsp nicox subject right pfizer with respect pfizer patent shall have step right obligation same manner provided clause with respect other insite technology table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign party pursuing suit action proceeding under clause shall provide reasonable assistance other party including being joined party plaintiff necessary prosecute such suit action proceeding providing access relevant document other evidence making employee available subject other party reimbursement reasonable pocket expense incurred enforcing defending party providing such assistance nicox also agrees provide same assistance pfizer insite required provide under pfizer agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign neither party shall settle otherwise compromise such suit action proceeding that creates obligation other party adversely affect other party right with respect insite technology without other party prior written consent which consent shall unreasonably withheld delayed addition without limiting foregoing with respect pfizer patent nicox shall settle otherwise compromise such suit action proceeding except permitted under pfizer agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign except otherwise agreed party part cost sharing arrangement settlement damage other monetary award recovery recovered pursuant suit proceeding action brought under clause shall allocated first cost expense party taking such action second cost expense other party extent otherwise reimbursed third remaining amount will divided between party proportion loss suffered each party provided that with respect recovery connection with pfizer patent recovery allocation forth this clause shall apply after deduction amount owed pfizer under pfizer agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign trademark table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign following effective date insite hereby assigns nicox insite mark listed appendix each party agrees promptly execute other instrument form assignment other document take such further action other party reasonably request order give effect evidence assignment this clause including registration nicox registered proprietor insite mark during term nicox shall responsible preparing filing document give effect assignment nicox shall reimburse insite request respect reasonable pocket cost other than legal incurred insite giving effect assignment upon early termination this agreement insite under clause upon early termination this agreement nicox under clause early termination pursuant clause early reversion right insite under clause nicox agrees assign insite mark back insite either their entirety respect country country within territory product product basis consistent with scope applicable termination reversion table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox will maintain insite mark during term nicox shall entitled trade mark exploit product field table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign country territory respect which insite already registered applies register insite mark registered trade mark nicox will entitled apply register insite mark nicox cost nicox name table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size connection with nicox insite mark pursuant right granted under this agreement nicox will comply with applicable territory nicox agrees extent such mark owned insite that will maintain quality standard product connection with which insite mark used insite mark adequate suited protection insite mark goodwill associated therewith including using appropriate trademark attribution notice appropriate style font size vertical align other symbol including using insite mark that would tend allow them lose their distinctiveness materially detrimental good name goodwill reputation insite table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign without limiting foregoing nicox will maintain quality standard product connection with which insite mark used insite mark that substantially equivalent nicox option stricter than those standard used nicox connection with other similar product territory order determine whether nicox compliance with this clause reasonable written request insite nicox reasonable expense nicox will provide insite with copy photograph representative sample advertising copy promotional material product sample other material bearing insite mark nicox covenant agrees that will insite mark connection with good product other than product field territory notwithstanding that such good product dissimilar product have different nicox acknowledges agrees that shall acquire shall claim title insite mark adverse insite virtue right granted under this agreement through nicox insite mark table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox continue name product listed appendix insite mark term extent nicox right under clause survive termination expiration provided clause including pursuant clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign compete table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite expressly acknowledges agrees that during period starting from effective date until payment period insite shall directly indirectly through affiliate other third party manner whatsoever table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign develop have developed have used commercialise permit foregoing product territory prevention treatment human disease condition table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign develop have developed have used commercialise permit foregoing product field territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such product durasite technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such product both table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign durasite formulation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign contains active ingredient that same active ingredient product table style margin margin bottom margin left font size font family time roman notwithstanding foregoing provision this clause will apply indication dexasite azasite plus bromdex style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign avoidance doubt nothing clause shall prohibit insite from directly indirectly through affiliate third party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign developing having developed making having made using having used commercialising product other product nbsp outside territory nbsp veterinary application whether inside outside territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign developing having developed making having made using having used nbsp product territory solely purpose commercialization outside territory nbsp product field territory solely purpose commercialization outside field outside territory provided that insite agrees that shall conduct clinical development product respect human territory without prior written consent nicox table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign carrying performing task responsibility under this agreement including pursuant clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite from applying durasite technology product controlled third party such third party develop commercialise field territory provided that such product compete with product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign term termination agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement shall effective effective date shall continue unless terminated earlier accordance with this clause until expiration payment period with regard product upon expiration this agreement nicox right licence with respect patented insite technology pursuant clause shall become fully paid perpetual royalty free licence avoidance doubt notwithstanding other provision this agreement nicox shall after payment period entitled manufacture sell product form which they have been sold prior fifth anniversary this agreement without payment insite regardless intellectual property right insite insite know with exception nbsp insite patented improvement where nicox entered into licence agreement after payment period pursuant clause nbsp insite patented improvement created after fifth style font size vertical align nbsp anniversary this agreement where nicox entered into licence agreement where such licence agreement required pursuant clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party shall subject applicable have right addition other right remedy terminate this agreement event other party defaulting party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign material breach obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case breach nicox that would cause insite breach under pfizer agreement event breach capable cure nicox fails remedy that breach within fifty nbsp written notice from insite requiring five nbsp business case breach with respect payment money table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign case other breach event breach capable cure fails remedy that breach within seventy five nbsp written notice from other party requiring case failure payment obligation exceeding hundred thousand thirty nbsp written notice from other party provided that party receiving such notice dispute that such breach there dispute whether such breach been remedied this agreement shall remain full force effect until final appealable judgment award rendered accordance with clause determined that this agreement been validly terminated table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign suffers insolvency event purpose this clause insolvency event mean relation defaulting party following table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign order made winding defaulting party except case voluntary winding purpose solvent amalgamation reconstruction table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign trustee bankruptcy appointed relation defaulting party such appointment challenged revoked within sixty nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign defaulting party unable debt they fall table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign without limiting right under clause nicox shall have right terminate this agreement without cause either entirety respect country country within territory product product basis providing prior written notice insite provided that such case insite shall entitled retain payment made nicox amount from nicox shall immediately paid insite table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement terminated time mutual agreement party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement terminated insite regard specified product should nicox affiliate challenge validity enforceability pfizer patent provided clause nicox shall terminate agreement relating specified product with pfizer patent licensee regard specified product should that licensee challenge validity enforceability pfizer patent nicox acknowledges that failure terminate such agreement will deemed material breach this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign unless otherwise agreed writing between party nicox undergoes nicox change control nicox successor entity applicable will required commercially reasonable effort launch exploit product field which effort must than effort employed intended employed resource used intended used nicox prior occurrence nicox change control taking into account market such product efficacy safety other relevant factor notwithstanding foregoing nothing this clause shall limit nicox obligation clause including clause furthermore unless otherwise agreed writing between party nicox undergoes nicox change control insite shall longer required license nicox insite improvement made after date such nicox change control table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign effect termination table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign expiration termination this agreement shall affect right party under this agreement that have accrued prior such expiration termination that survive accordance with this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign upon early termination this agreement reason other than termination nicox under clause subject clause either entirety respect country country within territory product product basis table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party shall promptly return other party certify destruction relevant record material possession control containing comprising other party confidential information except information record required retained party accordance with legal requirement regulatory requirement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign licence granted insite nicox under this agreement including under clause shall terminate table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign upon insite request nicox promptly shall nbsp assign surrender insite nbsp insite mark nbsp extent launched received marketing approval product under approved trade mark concerned country territory such approved trade mark such country sole discretion nicox such other brand name reasonably acceptable insite nicox will expense register with regulatory authority nbsp regulatory approval regulatory submission country europe forth appendix product nbsp commercially reasonable effort assign surrender nbsp regulatory approval regulatory submission remaining country territory excluding country europe product nbsp third party agreement extent that they relate solely product necessary development distribution manufacture other exploitation product territory excluding right trademark nicox other than approved trade mark nicox promptly shall execute other instrument form assignment other document take such further action insite reasonably request order give effect evidence foregoing assignment purpose this clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign insite shall permitted develop manufacture distribute otherwise exploit without interference nicox without regard provision clause product territory licence granted nicox insite clause shall expanded include foregoing table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox promptly shall cease cause affiliate nicox agent authorized resellers other licensee promptly cease sale product territory table style margin margin bottom margin left font size font family time roman provided that where nicox terminates only part this agreement pursuant clause this clause provision clause shall apply only with respect terminated country product style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign upon early termination this agreement nicox shall have right exclusive basis continue distribute product inventory nicox nicox agent authorized resellers other licensee date termination this agreement though this agreement been terminated period equal lesser nbsp shelf life such product nbsp month from effectiveness such termination provided however that nicox shall have paid insite such product manner herein provided table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement terminated nicox under clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign licence granted nicox under clause shall continue full force effect nicox shall continue have right exploit improve product field territory accordance with this agreement without prejudice right remedy have respect breach contract insite table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign nicox shall continue applicable payment under this agreement including pursuant clause table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign bankruptcy table style margin margin bottom margin left font size font family time roman licence right licence granted under pursuant this agreement party other party shall otherwise deemed purpose section nbsp title united state bankruptcy code code licence right intellectual property defined under section nbsp code party agree that each party licensee such right under this agreement shall retain fully exercise right election under code this agreement rejected behalf bankrupt party under code other party right under this agreement with respect access know will accelerate other party will immediately entitled copy such written material required clause provision this clause without prejudice right party licensee have arising under code other applicable party further agree that event commencement bankruptcy proceeding against party under code analogous provision applicable outside other party shall entitled complete duplicate complete access appropriate intellectual property licensed such other party embodiment such intellectual property which already such other party possession shall delivered immediately such other party unless bankrupt party elect continue continues perform obligation under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publicity table style margin margin bottom margin left font size font family time roman publication style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign insite nicox each acknowledge other party interest publishing result research development order obtain recognition within scientific community advance state scientific knowledge each party also recognizes mutual interest obtaining valid patent protection protecting business interest trade secret information consequently either party wishing make publication presentation comprising otherwise relating product equivalent product field excluding publication presentation currently being pursued insite shall deliver other party copy proposed written publication outline oral disclosure least thirty nbsp prior submission publication presentation reviewing party shall have right table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign object propose modification publication presentation patent reason trade secret reason other reason table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign request reasonable delay publication presentation order protect patentable information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign reviewing party request delay publishing party shall delay submission presentation period ninety nbsp enable patent application protecting either each party right such information filed accordance with clause upon expiration such ninety nbsp publishing party shall free proceed with publication presentation reviewing party object request modification publication presentation publishing party shall submit such publication presentation without prior written approval reviewing party such approval withheld without reasonable cause provided that publishing party shall have right publish confidential information reviewing party without prior written approval reviewing party publishing party shall provide reviewing party copy publication presentation time submission table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox acknowledges agrees that shall have right publish with respect durasite technology except extent relates product which publication will subject review provided this clause table style margin margin bottom margin left font size font family time roman publicity style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign publicity press release other announcement regarding this agreement transaction contemplated hereby shall reviewed advance subject written approval both party provided however that either party without written consent other disclose term this agreement permitted under clause each party reviewed approves joint press release appendix party shall required seek permission other party repeat disclose information regarding this agreement transaction contemplated hereby that already been publicly disclosed such party accordance with this clause other party equivalent information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign miscellaneous table style margin margin bottom margin left font size font family time roman amendment revision style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign provision either party business form correspondence including correspondence delivered through mail internet system shall supersede amend term this agreement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement only changed amended modified written amendment this agreement that signed authorized representative both party which expressly refers this agreement table style margin margin bottom margin left font size font family time roman assignability style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement shall binding upon inure benefit each party hereto their respective successor permitted assigns neither this agreement right obligation under assigned transferred either party without other party prior written consent which consent shall unreasonably withheld delayed conditioned provided however that either party assign right transfer obligation under this agreement without consent other party nbsp event sale such assigning party whether merger consolidation reorganization sale voting stock substantially asset such assigning party which this agreement relates nbsp company group provided that assigning party shall either remain liable assigned obligation liability duty under this agreement shall provide other party with parent company guarantee form reasonably acceptable other party attempted assignment transfer contrary foregoing shall deemed null void purpose this clause group mean either party ultimate holding company company which controlled such holding company controlled purpose this clause mean direct indirect ownership nbsp fifty cent nbsp more issued share other interest profit person nbsp ability otherwise control direct decision board director equivalent governing body thereof table style margin margin bottom margin left font size font family time roman binding effective date agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement shall binding upon party until been signed authorized representative each party which event shall effective effective date table style margin margin bottom margin left font size font family time roman construction style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement shall construed interpreted fairly accordance with plain meaning term there shall presumption inference against party drafting this agreement construing interpreting provision hereof table style margin margin bottom margin left font size font family time roman counterpart style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement executed facsimile multiple original counterpart each which will original which when taken together shall constitute same document table style margin margin bottom margin left font size font family time roman governing dispute resolution style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign this agreement shall exclusively construed governed controlled england without regard principle that would cause application other jurisdiction including conflict jurisdiction territory country province nation this governing provision applies matter where nicox insite headquartered office distributes product this agreement shall governed united nation convention contract international sale good application which expressly excluded table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign dispute controversy claim arising relating this agreement including breach termination invalidity thereof shall settled follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size prior bringing legal action against other party such dispute shall separately negotiated party hereto good faith commercially reasonable effort undertaken settle amicably such matter before resorting further legal recourse follows upon occurrence dispute between party including breach table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign this agreement obligation relating thereto dispute with respect whether product product matter shall referred first officer insite nicox having responsibility subject matter dispute their designees officer their designees case shall negotiate good faith resolve such dispute mutually satisfactory manner thirty nbsp such effort result mutually satisfactory resolution dispute matter shall referred insite authorized representative nicox authorized representative such authorized representative shall negotiate good faith resolve such dispute mutually satisfactory manner thirty nbsp additional such longer period time which representative agree table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign effort described clause above result mutually satisfactory resolution matter shall settled binding arbitration administered international chamber commerce accordance with rule conciliation arbitration effect date commencement arbitration subject provision this clause judgment award rendered arbitrator entered court having jurisdiction thereof arbitration shall conducted follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign number arbitrator shall three place arbitration shall paris france language used arbitration proceeding shall english table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign demand arbitration party initiating arbitration shall provide statement setting forth nature dispute name address other party estimate amount involved remedy sought otherwise specifying issue resolved appointing neutral arbitrator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign answering statement filed responding party within fifteen nbsp after confirmation notice filing demand sent responding party shall appoint neutral arbitrator table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within fifteen nbsp from date which responding party appoints neutral arbitrator first arbitrator shall appoint neutral chairperson table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party fails make appointment arbitrator provided clause nbsp above shall make appointment appointed arbitrator fail appoint chairperson within time specified clause above there agreed extension time appoint chairperson table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each arbitrator will professional training education other work experience have familiarity with licensing product development pharmaceutical product industry table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign arbitrator will have authority grant specific performance allocate cost between party including attorney provided that arbitrator will have authority award damage contravention this agreement each party irrevocably waif claim such damage contravention this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left viii align left valign party shall their commercially reasonable effort conduct dispute resolution procedure under this agreement expeditiously efficiently cost effectively possible table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman notwithstanding anything herein contrary nothing this agreement shall restrict either party time from seeking equitable relief prevent irreparable harm that caused other party actual threatened breach this agreement style margin margin bottom margin left font size font family time roman notice style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party hereto expressly consent service process being affected upon nbsp paid overnight carrier nbsp personal delivery sent address specified below such other address party designate receive service process which designation shall made pursuant clause table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign case insite valign bottom valign bottom case nicox style font size height height colspan style font family time roman font size valign style margin margin bottom font size font family time roman attn chief executive officer style margin margin bottom font size font family time roman insite vision incorporated style margin margin bottom font size font family time roman atlantic avenue style margin margin bottom font size font family time roman alameda california style margin margin bottom font size font family time roman valign bottom valign bottom style margin margin bottom font size font family time roman attn chief executive officer style margin margin bottom font size font family time roman nicox style margin margin bottom font size font family time roman drakkar acirc timent style margin margin bottom font size font family time roman route dolines style margin margin bottom font size font family time roman sophia antipolis style margin margin bottom font size font family time roman valbonne france style font size height height colspan style font family time roman font size valign style margin margin bottom font size font family time roman notice pursuant clause style margin margin bottom font size font family time roman facsimile valign bottom valign bottom style margin margin bottom font size font family time roman notice pursuant clause style margin margin bottom font size font family time roman facsimile style font size margin margin bottom nbsp style margin margin bottom font size font family time roman with copy executive vice president corporate development general counsel table style margin margin bottom margin left font size font family time roman entire agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign subject clause party have read this agreement appendix attached thereto which shall collectively referred agreement agree bound term further agree that constitutes complete entire agreement party with respect subject matter hereof supersedes previous contemporaneous communication correspondence agreement between party whether such agreement oral written including disclosure confidentiality agreement between party provided however that disclosure agreement entered into party dated nbsp november shall continue remain effect confidential information disclosed prior effective date this agreement outside scope this agreement except that addition confidential information disclosed party under such disclosure agreement prior effective date that within scope this agreement shall also deemed confidential information under this agreement subject clause representation statement kind made either party oral written which expressly stated herein shall binding such party except expressly stated herein each party hereby disclaims implied warranty including warranty merchantability fitness particular purpose infringement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign clause shall exclude limit liability fraud fraudulent misrepresentation table style margin margin bottom margin left font size font family time roman force majeure style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign align left style font family time roman font size party shall commercially reasonable effort perform their obligation hereunder however neither party shall responsible delay failure performance other than obligation make payment money extent they result from beyond reasonable control such party such shall include limited public enemy terrorism strike walkout riot epidemic failure supplier perform table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign governmental regulation power failure earthquake other natural disaster above provision shall release party from using commercially reasonable effort avoid remove such cause delay from immediately notifying other party writing soon knowledge delay further whenever such cause delay shall cease exist such party shall also immediately notify other party writing shall continue performance with reasonable promptness table style margin margin bottom margin left font size font family time roman notice provision style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notice pursuant this agreement shall writing given made upon party their respective address forth clause some other address party designate writing delivered other party notice required permitted given under this agreement shall either nbsp delivered personally nbsp delivered paid overnight service nbsp transmitted facsimile other similar mean electronic communication with copy sent personal delivery paid overnight service notice hereunder shall deemed communicated follows table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice delivered personally shall deemed given upon earlier occur date upon which actually received addressee date upon which delivery made such address confirmed courier table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice given paid overnight service shall deemed given upon earlier occur date upon which actually received addressee date upon which delivery made such address confirmed paid overnight courier table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice given facsimile transmission shall deemed given upon date actually received addressee confirmed electronic answerback return mail from addressee agent acknowledging receipt table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice given mail shall deemed given upon date actually received addressee confirmed electronic answerback return mail from addressee agent acknowledging receipt table style margin margin bottom margin left font size font family time roman provided however that notice received addressee location business based addressee local time such notice will deemed have been delivered addressee local time next business either party change contact person address notice mean written notice other party given accordance with this clause style margin margin bottom margin left font size font family time roman severability style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign event provision this agreement held court other tribunal competent jurisdiction unenforceable that provision will enforced maximum extent permissible under applicable other provision this agreement will remain full force effect unless unenforceable provision such essential importance this agreement that reasonably assumed that party would have entered into this agreement without unenforceable provision table style margin margin bottom margin left font size font family time roman survival style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding expiration termination this agreement following provision shall survive termination clause with respect final report upon expiration termination this clause together with term that expressly stated intended implication survive expiration termination this agreement other provision necessary interpretation enforcement table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom margin left font size font family time roman performance nicox company group style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign nicox perform obligation under this agreement either itself through company group contract right obligation under this agreement company group provided that nicox shall remain liable obligation liability duty under this agreement compliance those group member with this agreement same extent nicox table style margin margin bottom margin left font size font family time roman waiver style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign none provision this agreement shall deemed have been waived acquiescence either party except instrument writing signed authorized representative both party which expressly refers this agreement provision waiving such waiver waiver shall constitute waiver other provision this agreement same provision provision another occasion table style margin margin bottom margin left font size font family time roman certain remedy style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign each party acknowledges agrees that other party would irreparably damaged provision this agreement other than provision involving payment money performed party accordance with their specific term that breach failure perform comply with this agreement party could adequately compensated case monetary damage alone accordingly addition other right remedy which party entitled equity shall entitled enforce provision this agreement other than provision involving payment money decree specific performance temporary preliminary permanent injunctive relief prevent breach threatened breach provision this agreement without posting bond other undertaking table style margin margin bottom margin left font size font family time roman export control style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign notwithstanding other provision contained herein this agreement made subject applicable restriction concerning export product technical information from united state america that imposed from time time government united state america nicox agrees that shall export export directly indirectly product technical information acquired from insite product using derived from such technical information person country which united state government agency thereof time export requires export licence other governmental approval without first obtaining written consent from department commerce other relevant appropriate agency united state government when required applicable statute regulation table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman witness whereof party hereto their duly authorized representative have executed this agreement date forth below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width valign bottom width valign bottom width width valign bottom width width style font size height colspan height colspan height colspan height colspan style font family time roman font size valign colspan style margin margin bottom font size font family time roman insite valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom nicox style font size height colspan height colspan height colspan height colspan style font family time roman font size valign colspan style margin margin bottom font size font family time roman insite vision incorporated valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom nicox style font size height colspan height colspan height colspan height colspan style font family time roman font size valign colspan style margin margin bottom font size font family time roman authorized representative valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom authorized representative style font size height height colspan height colspan height colspan height colspan style font family time roman font size valign valign bottom valign style margin margin bottom border bottom solid font size font family time roman timothy ruane valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman michele garufi style font family time roman font size valign valign bottom valign align center style font size vertical align please print valign bottom valign bottom valign bottom valign bottom valign bottom valign bottom align center style font size vertical align please print style font family time roman font size valign signature valign bottom valign style margin margin bottom border bottom solid font size font family time roman timothy ruane valign bottom valign bottom valign bottom valign bottom signature valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman michele garufi style font family time roman font size valign title valign bottom valign style margin margin bottom border bottom solid font size font family time roman chief executive officer valign bottom valign bottom valign bottom valign bottom title valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman chairman chief executive officer style font family time roman font size valign date nbsp signed valign bottom valign style margin margin bottom border bottom solid font size font family time roman january nbsp valign bottom valign bottom valign bottom valign bottom date nbsp signed valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman january table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center product initial indication style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists three page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center country territory style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center insite mark style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center existing insite patent style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center more style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center pfizer patent style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center part agreement style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists three page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center outline development activity style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center part style margin margin bottom font size font family time roman align center nicox press release style font size margin margin bottom nbsp style margin margin bottom align right logo style margin margin bottom font size font family time roman nicox sign exclusive license agreement with insite style margin margin bottom font size font family time roman vision azasite style font size vertical align bromsite europe style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign insite grant nicox exclusive license azasite style font size vertical align azithromycin bromsite bromfenac azasite xtra azithromycin europe middle east africa table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left width valign nbsp align left valign european regulatory filing azasite style font size vertical align bromsite planned table style margin margin bottom font size font family time roman february nbsp style margin margin bottom font size font family time roman sophia antipolis france style margin margin bottom font size font family time roman nicox nyse euronext paris today announced signature license agreement with insite vision otcbb insv development manufacture commercialization insite innovative ophthalmic therapeutic azasite style font size vertical align azithromycin bromsite bromfenac azasite xtra azithromycin three product based insite proprietary durasite style font size vertical align drug delivery technology which designed extend duration drug style margin margin bottom font size font family time roman agreement grant nicox exclusive right three product europe middle east africa european marketing authorization application maas azasite style font size vertical align bromsite expected filed with first launch expected late style margin margin bottom font size font family time roman philippe masquida executive vice president managing director european international operation nicox pharma said this agreement give nicox access three patented formulation molecule which already well known europe using durasite proven drug delivery technology extend residence time drug azasite style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman bromsite have potential offer european ophthalmologist treatment option bacterial conjunctivitis post operative pain inflammation look forward bringing these differentiated product important market which have seen little innovation recent year style margin margin bottom font size font family time roman emerging international ophthalmology company with established operational infrastructure main european market well growing network international distributor believe nicox right strategic partner accelerate commercialization realize full potential durasite based product said ruane chief executive officer insite vision this agreement allows further advance develop technology ophthalmologic product addressing care need patient around world style margin margin bottom font size font family time roman azasite style font size vertical align azithromycin approved canada treatment bacterial conjunctivitis marketed insite licensee akorn bromsite bromfenac been developed treatment inflammation prevention pain after cataract surgery based positive data from pivotal phase clinical study insite intends file drug application with food drug administration bromsite first quarter style margin margin bottom font size font family time roman nicox planning target same ophthalmic indication europe middle east africa azasite style font size vertical align bromsite which would compete market estimated worth more than million style font size vertical align style margin margin bottom font size font family time roman company evaluating most appropriate indication development path azasite xtra azithromycin which earlier development stage style margin margin bottom font size font family time roman term exclusive license agreement style margin margin bottom font size font family time roman under term agreement nicox will make upfront payment million make further regulatory commercial milestone payment total nbsp million financial term also include tiered single digit double digit royalty style margin margin bottom font size font family time roman nicox will sponsor manage further development required registration product europe middle east africa further clinical study expected required prior filing azasite style font size vertical align bromsite nicox will have right data from azasite style font size vertical align registration bromsite study regulatory submission approval these product territory covered agreement azasite xtra expected development project style margin margin bottom font size font family time roman joint collaboration development committee will oversee development activity both company also collaborate developing additional indication product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman about insite durasite style font size vertical align platform style margin margin bottom font size font family time roman durasite sustained delivery technology using synthetic polymer based formulation designed extend time drug relative conventional topical therapy this important because drainage system extremely efficient eliminating topically instilled medication often result administered drug being lost first second after delivery style font size vertical align increased time that durasite style font size vertical align remains allows lower concentration drug administered over longer period time this provides more convenient dosing reduces potential adverse side effect lead improved patient compliance style margin margin bottom font size font family time roman reference style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign sale ophthalmic anti infective steroidal anti inflammatory drug europe middle east africa health september table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign john shell pharmacokinetics topically applied ophthalmic drug january february survey ophthalmology table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom about nicox valign bottom valign bottom align right logo table style margin margin bottom font size font family time roman nicox bloomberg reuters ncox emerging international company focused ophthalmic market with heritage innovative business development commercial expertise nicox team building diversified portfolio ophthalmic product that help people enhance their sight company established direct commercial operation main european market well expanding international network distributor style margin margin bottom font size font family time roman nicox pipeline feature several near term therapeutic including vesneo latanoprostene bunod novel compound based nicox proprietary nitric oxide donating research platform currently phase with bausch lomb glaucoma ocular hypertension cetirizine drop which completed phase allergic conjunctivitis company also conducting other research program based donating platform style margin margin bottom font size font family time roman nicox headquartered france listed euronext paris compartment more information nicox product please visit nicox style margin margin bottom font size font family time roman this press release contains certain forward looking statement although company belief expectation based reasonable assumption these forward looking statement subject numerous risk uncertainty which could cause actual result differ materially from those anticipated forward looking statement style margin margin bottom font size font family time roman risk factor which likely have material effect nicox business presented style font size vertical align chapter document eacute eacute rence rapport financier annuel rapport gestion filed with french autorit eacute march eacute financier april nbsp style font size vertical align rapport semestriel financier activit eacute juin style font size vertical align chapter actualisation document style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman eacute eacute rence filed with september nbsp section document registered with september nbsp these document available nicox website nicox style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign bottom contact valign bottom valign bottom valign bottom valign rowspan align right logo style font family time roman font size valign nicox valign bottom valign bottom gavin spencer executive vice president corporate development valign bottom style font family time roman font size valign valign bottom valign bottom communication nicox valign bottom valign bottom style font size height height colspan height colspan style font family time roman font size valign medium nbsp relation valign bottom valign bottom valign bottom valign bottom style font size height height colspan height colspan style font family time roman font size valign united nbsp kingdom valign bottom valign bottom jonathan birt valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom nbsp jonathan birt ymail valign bottom valign bottom style font size height height colspan height colspan style font family time roman font size valign france valign bottom valign bottom caroline cour communication manager valign bottom valign bottom style font family time roman font size valign valign bottom valign bottom courme nicox valign bottom valign bottom table style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nicox style margin margin bottom font size font family time roman drakkar acirc route dolines sophia antipolis valbonne france style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman nicox style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center part style margin margin bottom font size font family time roman align center insite press release style font size margin margin bottom nbsp style font size margin margin bottom nbsp style margin margin bottom align right logo style margin margin bottom font size font family time roman align center insite vision announces license agreement azasite style font size vertical align azasite xtra style margin margin bottom font size font family time roman align center bromsite europe middle east africa style margin margin bottom font size font family time roman align center company will receive upfront payment million potentially more than style margin margin bottom font size font family time roman align center million milestone payment addition royalty style margin margin bottom font size font family time roman alameda california february nbsp insite vision incorporated otcbb insv today announced that entered into license agreement with nicox nyse euronext paris france based publicly traded company development commercialization insite innovative ophthalmic therapeutic product azasite azithromycin azasite xtra azithromycin bromsite bromfenac formulated insite durasite style font size vertical align drug delivery system agreement grant nicox exclusive right commercialize three product europe including eastern europe middle east africa emea nicox expects file european marketing authorization maas azasite bromsite with first commercial launch late style margin margin bottom font size font family time roman nicox emerging international ophthalmology company with established commercial infrastructure main european market well growing network international distributor believe nicox right strategic partner accelerate commercialization durasite based product said timothy ruane insite vision chief executive officer this agreement allows bring innovative product addressing significant care need patient large part globe style margin margin bottom font size font family time roman under term licensing agreement insite will receive upfront payment million potentially million milestone payment upon product launch insite will also receive tiered single digit double digit royalty style margin margin bottom font size font family time roman azasite approved united state canada treatment bacterial conjunctivitis marketed akorn bromsite being developed treatment inflammation prevention pain after cataract surgery based positive data from pivotal phase clinical study insite intends file drug application with style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman food drug administration bromsite first quarter nicox planning target same ophthalmic indication emea territory azasite bromsite these product will compete market estimated more than million style margin margin bottom font size font family time roman company evaluating most appropriate indication development path azasite xtra which completed clinical testing program style margin margin bottom font size font family time roman nicox will manage further development required registration azasite bromsite emea further clinical study expected required prior filing maas these product europe joint collaboration development committee will oversee development activity company collaborate developing additional indication product style margin margin bottom font size font family time roman about insite vision style margin margin bottom font size font family time roman insite vision advancing ophthalmologic product unmet care need based innovative durasite style font size vertical align platform technology durasite durasite drug delivery system extend duration drug retention surface thereby reducing frequency treatment improving efficacy topical drug style margin margin bottom font size font family time roman durasite platform currently leveraged commercial product treatment bacterial infection azasite style font size vertical align azithromycin ophthalmic solution marketed akorn besivance style font size vertical align besifloxacin ophthalmic suspension marketed bausch lomb wholly owned subsidiary valeant pharmaceutical international insite vision also advancing azasite plus novel ophthalmic therapeutic through phase clinical study treatment infection preparing drug application commercial approval food drug administration bromsite treatment inflammation prevention pain associated with cataract surgery dexasite style font size vertical align treatment blepharitis further information insite vision please visit insitevision style margin margin bottom font size font family time roman forward looking statement style margin margin bottom font size font family time roman this news release contains certain statement forward looking nature relating future event including timing likelihood filing azasite european union bromsite united state european union respectively that european regulatory authority require further study additional information prior filing maas approve such maas expected timing commercialization azasite bromsite europe potential market size azasite bromsite europe company current plan pursue regulatory approval product candidate potential indication company pipeline drug candidate such statement entail number risk uncertainty including limited company ability obtain substantial additional funding ability company file receive approval bromsite nicox file receive approval maas europe timing thereof company reliance nicox perform obligation under license agreement successfully develop obtain approval commercialize azasite bromsite that company receive milestone payment royalty under license agreement ability company enter into corporate collaboration product candidate company ability expand product platform including azasite xtra company ability compete effectively either alone through partner with other company offering competing style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman product treatment company ability maintain develop additional collaboration commercial agreement with corporate partner ability adequately protect intellectual property free operate with regard intellectual property others determination reference made discussion these other risk factor detailed company filing with security exchange commission including annual report form quarterly report form under caption risk factor elsewhere such report forward looking statement projection based limited information currently available company which subject change although such forward looking statement projection factor influencing them will likely change insite vision undertakes obligation update forward looking information such information speaks only date release actual event result could differ materially should unduly rely such statement information assume that information provided this release still valid later date style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman azasite style font size vertical align durasite style font size vertical align registered trademark insite vision incorporated style margin margin bottom font size font family time roman azasite plus bromsite dexasite bromdex trademark insite vision incorporated style margin margin bottom font size font family time roman besivance style font size vertical align registered trademark bausch lomb incorporated style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman contact information style margin margin bottom font size font family time roman insite vision style margin margin bottom font size font family time roman louis drapeau chief financial officer style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman mail insite style margin margin bottom font size font family time roman medium investor inquiry style margin margin bottom font size font family time roman partner style margin margin bottom font size font family time roman karen bergman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman susan pietropaolo style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center more style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center custom manufacturing equipment style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center development activity style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman appendix consists page redacted filed separately with commission pursuant insite vision incorporated request confidential treatment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center disclosure schedule style margin margin bottom font size font family time roman ucsf patent interference case university california francisco ucsf claimed that invention contained patent were made former employee university alone without collaboration with insite assignee named inventor united state patent trademark office entered their judgment against ucsf claim november court appeal federal circuit affirmed that judgment nbsp october usdc jersey entered final judgment finding asserted claim patent valid infringed sandoz filed appeal this judgment nbsp november united state court appeal federal circuit style margin margin bottom font size font family time roman sandoz anda paragraph case sandoz filed abbreviated drug application anda with food drug administration seeking market generic version azasite style font size vertical align azithromycin ophthalmic solution before expiration patent covering azasite insite joined merck pfizer filing patent infringement lawsuit against sandoz style margin margin bottom font size font family time roman mylan anda paragraph case mylan pharmaceutical filed abbreviated drug application anda with seeking market generic version azasite style font size vertical align azithromycin ophthalmic solution before expiration patent covering azasite nbsp june insite merck pfizer filed patent infringement lawsuit against mylan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission style page break before always size style color width align center style margin margin bottom font size font family time roman align center appendix style margin margin bottom font size font family time roman align center pfizer agreement style margin margin bottom font size font family time roman align center exclusive license agreement style margin margin bottom text indent font size font family time roman exhibit insite vision incorporated quarterly report form file nbsp filed with security exchange commission nbsp security exchange commission granted confidential treatment certain portion exclusive license agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center confidential material redacted separately filed with commission body html text document